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This is the second of two reviews that is intended to cover the essential aspects of cardiovascular magnetic resonance
(CMR) physics in a way that is understandable and relevant to clinicians using CMR in their daily practice. Starting with
the basic pulse sequences and contrast mechanisms described in part I, it briefly discusses further approaches to
accelerate image acquisition. It then continues by showing in detail how the contrast behaviour of black blood fast
spin echo and bright blood cine gradient echo techniques can be modified by adding rf preparation pulses to derive a
number of more specialised pulse sequences. The simplest examples described include T2-weighted oedema imaging,
fat suppression and myocardial tagging cine pulse sequences. Two further important derivatives of the gradient echo
pulse sequence, obtained by adding preparation pulses, are used in combination with the administration of a
gadolinium-based contrast agent for myocardial perfusion imaging and the assessment of myocardial tissue viability
using a late gadolinium enhancement (LGE) technique. These two imaging techniques are discussed in more detail,
outlining the basic principles of each pulse sequence, the practical steps required to achieve the best results in a
clinical setting and, in the case of perfusion, explaining some of the factors that influence current approaches to
perfusion image analysis. The key principles of contrast-enhanced magnetic resonance angiography (CE-MRA) are also
explained in detail, especially focusing on timing of the acquisition following contrast agent bolus administration, and
current approaches to achieving time resolved MRA. Alternative MRA techniques that do not require the use of an
endogenous contrast agent are summarised, and the specialised pulse sequence used to image the coronary arteries,
using respiratory navigator gating, is described in detail. The article concludes by explaining the principle behind phase
contrast imaging techniques which create images that represent the phase of the MR signal rather than the
magnitude. It is shown how this principle can be used to generate velocity maps by designing gradient waveforms
that give rise to a relative phase change that is proportional to velocity. Choice of velocity encoding range and key
pitfalls in the use of this technique are discussed.
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reproduction in any medium, provided the orwith the principles of cardiac synchronisation and fast
(or turbo) imaging pulse sequences and how these can
be combined to achieve imaging of the heart within a
single patient breath-hold [1]. Part I is concluded by de-
scribing the two most commonly used cardiac MR im-
aging techniques; anatomical imaging using a double
inversion, black-blood spin echo pulse sequence and
bright blood functional cine imaging using either spoiled
gradient echo or balanced steady state free precession
(bSSFP) imaging pulse sequences.
Part II of this review aims to cover the remaining im-
aging techniques that are commonly used in cardiac MRl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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further in-depth coverage of the techniques discussed
here [2-9]. Each technique can be considered as being
based upon either the spin echo or gradient echo pulse
sequences already described in part I, but with certain
modifications applied to their contrast behaviour or
mode of acquisition. Three main approaches to the
modification of contrast behaviour are discussed. Firstly,
it is shown how radiofrequency (rf ) preparation pulses
can be added to existing pulse sequences to alter their
contrast behaviour: An inversion pulse added to a black-
blood FSE/TSE pulse sequence enhances T1 and T2
weighted contrast for imaging of myocardial oedema
[10]. A fat suppression pulse added to an existing pulse
sequence selectively suppresses the MR signal contribu-
tion from lipid based tissues [11], thus improving the de-
lineation of non-lipid based structures. More complex
preparation pulses may also be added to the cine gradient
echo pulse sequence to apply a line or grid pattern to
achieve myocardial tissue tagging that allows visualisation
of intra-myocardial motion [12,13].
The second method of modifying the MR contrast be-
haviour is through the intravenous administration of an
endogenous contrast agent, based on the paramagnetic
Gadolinium (Gd) ion [14]. This contrast agent is used in
two of the key CMR applications for the imaging of is-
chaemic heart disease; myocardial perfusion imaging
[15,16] and late gadolinium enhancement (LGE) imaging
[17,18]. Both of these techniques combine the use of
preparation pulses and the administration of a Gd-based
contrast agent to achieve T1 contrast weighting. The use
of contrast agent also provides the basis of contrast
enhanced MR angiography (CE-MRA) which is now in
widespread use to image most major vessels outside the
























*Self calibrating (auto-calibrating) techniques – reference data acquired as part of a
Summary of acceleration techniques where the data acquisition time is shortened bthat do not make use of Gd-based contrast agent are also
summarised. Imaging of the coronary arteries is most
commonly performed without the use of contrast agent.
The most common approach, performed with the patient
free-breathing and using navigator echoes for gating of
the respiratory cycle [20,21], is described in detail.
The third contrast mechanism that is discussed in this
review differs somewhat from the first two. Whereas for
all of the techniques discussed so far, the MR image
pixel intensity depends on the magnitude of the MR sig-
nal intensity, for phase contrast techniques the image
pixel intensity is related to the phase of the MR signal.
In this section it will be shown how the imaging gradients
can be used to encode the velocity of blood flowing along
a particular gradient direction to generate a relative phase
change that is proportional to velocity [22-24]. This pro-
vides a quantitative measure of blood velocity and blood
flow and has particular application in valvular and con-
genital heart disease.
All of the above techniques make use of the segmen-
ted k-space fast imaging techniques (either turbo/fast
spin echo or turbo/fast gradient echo) described in part
I to ensure that image acquisition can be performed
within an acceptable breath-hold period, or in the case
of perfusion imaging, within a single heart beat. A num-
ber of other acceleration techniques are used to further
reduce acquisition times to provide shorter breath-hold
periods or to improve temporal and spatial resolution.
Although a detailed description of these techniques is
beyond the scope of this review, they are briefly sum-
marised in the following section.
More acceleration techniques
The acceleration techniques described here and sum-












y reducing the number of phase encoding steps.
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number of k-space lines, to achieve the reduction in ac-
quisition time. Some of these techniques have been in
long-standing widespread use, such as the reduction of
image acquisition matrix size and/or field of view in the
phase encoding direction [25,26] and the acquisition of
data for only just over half of k-space, exploiting the sym-
metry property of k-space [25,27]. More complex k-space
under-sampling techniques, in which additional lines of
k-space can be omitted where there is redundancy of in-
formation, have come into use. The most established of
these techniques, parallel imaging [28-30], was made
possible with the adoption of multi-element rf receiver
coil arrays. Parallel imaging makes use of the geometricFigure 1 Parallel imaging. Parallel imaging uses the spatial distribution o
spatial information. This allows under-sampling of k-space (skipping of pha
acquisition time. (a) shows a full k-space acquisition without parallel imagin
are combined in phased-array mode to provide uniform signal intensity ac
with a reduction factor of 2 (2x SENSE) leads to skipping of alternate lines o
effective reduction of the field of view and image aliasing or ‘foldover’. As
obtained for each coil element. In (c) the SENSE reconstruction uses the im
elements, together with the coil element sensitivity maps acquired from a
image with a full field of view.distribution of the array coil elements to restore informa-
tion that is lost by acquiring a reduced number of
phase encoding steps (known as k-space under-sampling)
(Figure 1). The number of acquired phase encoding steps
is reduced by a certain factor, known as the reduction
factor, R. MR signal data covering the same extent of k-
space is acquired, preserving the spatial resolution, but
fewer lines of k-space are acquired, spaced further apart
(Figure 1b). This would normally result in aliasing of in-
formation in the phase encoding direction with signal
wrapping round from one side of the image to the oppos-
ite side. The distribution of at least two elements of an rf
coil array, along the phase encoding direction provides
information about the true location of the signal. Thef coil array elements and their characteristic sensitivity maps to provide
se encoding steps) during the acquisition, shortening the image
g. Image signal intensities from anterior and posterior coil elements
ross the field of view. (b) Parallel imaging using the SENSE method
f k-space. Without the SENSE reconstruction this would lead to an
an intermediate reconstruction step, separate aliased images are
ages obtained separately from the posterior and anterior coil
reference scan to remove the aliasing and reconstruct an unfolded the
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sensitivity, a measure of how the detected signal intensity
varies with distance from each coil element. Full image
reconstruction is achieved by using the signal from each
coil element, together with the coil sensitivity informa-
tion to produce an image without aliasing (Figure 1c).
This reconstruction step can either be performed in the
image space (SENSE, ASSET) or in k-space (SMASH,
GRAPPA, ARC). A knowledge of the coil sensitivity map
or signal intensity distribution for each patient, coil array
element and image slice geometry is essential for this
technique to work. Sensitivity maps are formed from the
central lines of k-space and can either be acquired as a
separate reference scan (as with SENSE or ASSET), or
concurrently as part of the acquisition (mSENSE,
GRAPPA, ARC).
Parallel imaging techniques are mainly used to reduce
imaging time, especially to shorten breath-hold periods,
but may also be used to improve either temporal or
spatial resolution for the same imaging time. There are
however drawbacks of parallel imaging: The imageFigure 2 The three most commonly used magnetisation preparation
sequence. Beneath each pulse sequence, curves show the behaviour of th
Spoiler gradients, S are applied to suppress any unwanted transverse magn
saturation pulse the z-magnetisation for all tissues is reduced to zero and r
sequence is applied after a delay TS the resultant contrast is T1-weighted w
following the 180° inversion pulse the z-magnetisation for all tissues is inve
pulse sequence is applied after a delay TI, the tissue for which its z-magne
the signal contribution from that tissue. In this example, the signal from m
is applied only at the resonant (Larmor) frequency of fat so that only the z
pulse sequence is applied with no delay. The z-magnetisation of other tissu
will yield normal signal levels.signal-to-noise ratio is reduced according to the square
root of the reduction factor. For a reduction factor of 2,
this results in a reduction of the signal-to-noise ratio by
approximately 30 %, and so parallel imaging should only
be applied when the image signal-to-noise ratio is suffi-
cient to accommodate such a reduction. Furthermore, if
the field of view in the phase encoding direction is set
too small, residual aliasing or foldover artefacts will ap-
pear at the centre of the image which cannot be
removed by the parallel imaging reconstruction, so care-
ful selection of the field of view and image orientation is
needed. The phase encoding direction in which the par-
allel imaging reduction factor is applied must also always
be chosen along a direction where there is a favourable
distribution of array coil elements. Otherwise the recon-
struction will fail leading to high noise levels at the
centre of the image.
More recently k-space under-sampling techniques that
make use of information that is repeated over time have
been developed for cine and dynamic imaging [31,32]
and are being translated into products.pulses, showing their relation to the image data acquisition pulse
e z-magnetisation for three different tissues (fat, muscle and fluid).
etisation produced by the preparation pulses. In (a) following the 90°
ecovers according to their T1 relaxation rate. When the imaging pulse
ith the shortest T1 (fat) yielding the highest signal intensity. In (b)
rted, and then recovers from a negative value. When the imaging
tisation is passing through zero yields no signal, effectively suppressing
uscle is suppressed. In (c) The frequency-selective fat suppression pulse
-magnetisation of fat-based tissue is reduced. In this case the imaging
es (muscle and fluid) are unaffected by the fat suppression pulse and
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Preparation pulses – general principles
Preparation pulses are rf pulses that are combined with
either spin echo or gradient echo pulse sequences to
modify their contrast behaviour. In part I of this review
it was shown how the MR signal produced by a spin
echo or gradient echo pulse sequence depends upon the
value of the net magnetisation immediately prior to each
repetition of the pulse sequence. This depends on factors
such as the flip angle of the rf excitation pulse, the time
between each repetition (the repetition time, TR) and
the rate at which the net magnetisation returns to its
starting value at equilibrium (determined by T1 relax-
ation with a characteristic time constant, T1, for a par-
ticular tissue). Preparation pulses are applied in order to
further prepare the net magnetisation before the stand-
ard pulse sequence is applied, a process known as mag-
netisation preparation. The most common preparation
pulses are saturation pulses, inversion pulses and fre-
quency selective fat-suppression pulses (Figure 2). Satur-
ation and inversion pulses are typically followed by a
prescribed time delay to allow recovery of the prepared
magnetisation before a spin echo or gradient echo pulse
sequence is used to ‘read out’ the MR signal. These tech-
niques are known as saturation recovery and inversionFigure 3 STIR, FLAIR and Black-Blood Preparation schemes. Pulse sequ
cases of the inversion recovery preparation scheme. In (a) the short TI inve
to the null point for fat tissue (TIfat) resulting in the suppression of signal fr
magnetisation is ignored and the displayed signal intensity from the other
highest signal intensity. In (b) the fluid attenuated inversion recovery (FLAIR
suppress the signal from fluid (TIfluid). In (c) the first inversion pulse of the b
null point for blood (TIblood). This pulse is non-slice-selective and so causes
inversion pulse is needed to undo the inversion applied to the tissues with
would also be suppressed. The combined effect of the two inversion pulse
slice. The subsequent wash-in of inverted blood into the image slice duringrecovery respectively and the associated delay times are
known as the time from saturation, TS, and the time
from inversion, TI (Figure 2a and Figure 2b). Frequency
selective fat-saturation pulses are applied immediately
before the readout pulse sequence to minimise recovery
of the net magnetisation arising from fat-based tissues
(Figure 2c). In general radiology applications, the inver-
sion recovery technique is commonly employed to sup-
press signal from selected tissues. This is done by
choosing the inversion time to coincide with the time at
which the recovering net magnetisation of a particular
tissue passes through zero, the null point (see
Figure 2b). For non-cardiac applications, the two most
common instances of the inversion recovery technique
are Short TI Inversion Recovery (STIR) [33,34] with the
TI chosen to correspond to the null point for fat tissue
(Figure 3a), thus resulting in the suppression of signal
from fat, and Fluid Attenuated Inversion Recovery
(FLAIR) [35] with the TI chosen to be at the null point
for fluid (Figure 3b), specifically, to suppress the signal
from cerebrospinal fluid for applications in the brain.
For cardiac applications, this same principle is used
when applying the black blood preparation scheme,
described in Part I [1]. This preparation scheme is used
to improve the suppression of blood signal in blackence timing and z-magnetisation curves for the three common special
rsion recovery (STIR) pulse sequence has the TI chosen to correspond
om fat. Note that for a modulus reconstruction, the sign of the
tissues increases with increasing T1 value, with fluid yielding the
) pulse sequence has the TI chosen to be at the null point for fluid to
lack-blood preparation scheme has its TI chosen to correspond to the
the inversion of magnetisation for all tissues. The second slice-selective
in the imaged slice (myocardial muscle, fat), otherwise their signals
s is therefore to invert the tissues including blood outside the imaged
the TI period results in suppression of signal from the blood pool.
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pulse sequences. In this case, the TI is chosen to corres-
pond to the null point for blood (Figure 3c), however
two 180° preparation pulses are needed for if only a sin-
gle inversion is used, the signal from the myocardium
within the imaging slice would also be partially sup-
pressed. The combined application of non-selective and
selective pulses causes only the blood outside the slice to
be inverted, leaving the myocardium to produce a signal
that is unmodified by the preparation scheme.
STIR, Triple IR and oedema imaging
In general radiology applications the STIR technique is
useful not only because it suppresses the signal from fat.
The inversion pulse applied with a short TI value
reduces the signal intensity from tissues with a shorter
T1 so that tissues with higher T1 relaxation times ex-
hibit a relatively higher signal magnitude. Because this
contrast behaviour (increasing signal with increasing T1)
is different from that of standard T1-weighted spin echo
techniques, it can also be combined with T2 weighting
by increasing the echo time, TE, to further enhance the
contrast where there is both an increased T1 and T2, for
example, in tissue oedema. The STIR technique requires
a long repetition time (similar to that required to achieve
T2 weighting for spin echo sequences) so although STIR
imaging can be applied using a standard spin echo pulseFigure 4 Triple IR Preparation scheme for Oedema imaging. Triple inv
used for oedema imaging. In (a) the pulse sequence timing is shown toge
the two 180° pulses for the black blood preparation, followed by a third sli
two inversion times, TIblood and TIfat. TIfat has the same value as that used f
Calculation of the value for TIblood depends on the heart rate, and the effec
curve shown for blood assumes it washes into the slice after the third 180°
plane using the black-blood turbo STIR technique. The intrinsic fluid weigh
long TE value (100 ms) to introduce T2-weighting (the technique is someti
as an area of increased signal (arrow). (Image courtesy of Darach O h-lci ansequence for data acquisition, this results in very long
acquisition times. It is therefore more common to com-
bine the STIR technique with fast or turbo spin echo
pulse sequences in order to reduce the acquisition time
to acceptable limits and this technique is often referred
to as turboSTIR. For cardiac applications, the TR is
defined by triggering from every second or third heart
beat, and the black blood preparation scheme is added
to suppress the signal from blood (Figure 4a). The re-
sultant black blood turbo STIR pulse sequence has
strong fluid weighting but with no signal from blood
within the cardiac chambers and it is particularly useful
for the assessment of myocardial oedema (Figure 4b). It
consists of the two 180° pulses for the black blood prep-
aration, followed by a third, normally slice-selective, 180°
pulse to provide the STIR contrast [10]. It is therefore
sometimes known as a triple inversion recovery pulse se-
quence. The sequence has two inversion times, TIBlood
and TIfat. TIfat has the same value for fat suppression as
in the STIR sequence (approx 160 milliseconds). Calcu-
lation of the value for TIBlood is more complicated and
depends on the heart rate and the number of heart beats
between trigger pulses. Some vendors enable the oper-
ator to select the third 180° pulse as either a slice-
selective or non-slice -selective pulse, and this must be
taken into account in the calculation of TIBlood. The set-
ting of other imaging parameter values is similar to theersion recovery TSE (Black-Blood turboSTIR) pulse sequence commonly
ther with z-magnetisation curves. The preparation scheme consists of
ce-selective 180° pulse to provide the STIR contrast. The sequence has
or fat suppression as in the STIR sequence (approx 160 milliseconds).
tive TR (number of heart beats per repetition). The z-magnetisation
pulse has been applied. The image in (b) is acquired in the short axis
ting of the STIR technique has been further enhanced by selecting a
mes referred to as T2-weighted STIR). Myocardial oedema can be seen
d Daniel Messroghli, Deutsches Herzzentrum, Berlin).
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described in Part 1 [1].
Frequency selective fat suppression
An alternative method of achieving suppression of the
signal from fat-based tissue is to exploit the difference in
Larmor frequency between the hydrogen nuclei in lipid
molecules and water molecules [33,36]. This difference,
known as the chemical shift, is equal to 3.5 parts per
million of their Larmor frequency (Figure 5a). At 1.5 T
this is a difference of approximately 220 Hz. The signal
from the lipid molecules is suppressed by applying a 90°
rf pulse at the Larmor frequency of fat (Figure 5a). As
no magnetic field gradient is applied, this pulse will sat-
urate (reduce to zero) the z-magnetisation of fat within
the entire imaging volume, provided that the Larmor
frequency is constant (i.e. the magnetic field is uniform
throughout the imaging volume). The transverse mag-
netisation produced by the rf pulse is de-phased using a
spoiler gradient and the pulse sequence used for image
data acquisition is then applied immediately afterwards
(Figure 2c). As the fat magnetisation is already saturated
by the fat suppression pulse, it does not contribute any
signal and appears on the image as a signal void. This
frequency-selective method of fat suppression is also
known as chemical shift selective (CHESS) imaging [36].
For fat suppression to be achieved uniformly across the
whole image, there is a particular requirement for the
magnetic field to be uniform to a much higher specifica-
tion than is normally required for imaging (although
Balanced SSFP imaging also requires a similarly high
uniformity). In addition to intrinsic variation in the mag-
netic field, there are also patient-induced variations that
require patient-specific adjustment of the magnet fieldFigure 5 Frequency selective fat suppression. MR signal contributions f
Larmor frequency. Both the lipid and water populations exhibit a small ran
interactions, however the central frequency of the lipid population is shifte
shielding effect of the electron cloud surrounding the larger lipid molecule
Shift Selective or CHESS pulse) is applied at the Larmor frequency of the lip
image data acquisition pulse sequence is then applied immediately after th
using a black blood TSE pulse sequence are shown without (top row) anduniformity. This adjustment, know as dynamic shim-
ming, is performed as part of the pre-scan adjustments
by adding small gradient magnetic fields applied using
the gradient coils, and on some MR systems an add-
itional set of dedicated shim coils. Frequency selective
fat suppression has the advantage that it can be applied
to any pulse sequence (gradient or spin echo, T1- or T2-
weighted) without altering the intrinsic contrast behav-
iour, other than the suppression of fat signal (Figure 5b).
As the success of this technique relies on a uniform
magnetic field, it does not work well in patients with
metallic implants located close to the region of interest.
It is used in clinical applications where it is desirable to
suppress the high signal intensity from fat-based struc-
tures that would otherwise mask adjacent structures or
areas of increased signal intensity. Frequency selective
fat suppression is often combined with T2-weighted
black blood turbo spin echo as an alternative to T2-
weighted black blood turboSTIR for imaging of oedema.
Cine myocardial tagging with spatial modulation of
magnetisation (SPAMM)
Imaging of heart wall motion is routinely performed
using cine gradient echo pulse sequences. In addition, it
is possible to assess intra-myocardial motion by ‘tagging’
the myocardium at end diastole with a line or grid pat-
tern, which then deforms as the heart wall contracts
[37]. Myocardial tagging is achieved using a specialised
preparation scheme consisting of series of non-selective
rf preparation pulses, (together known as a composite or
binomial rf pulse) combined with a series of gradient
pulses, known as modulating gradients (Figure 6a). The
effective flip angle of the composite rf pulse is around
90°. The modulating gradients are applied in betweenrom lipid and water molecules are plotted in (a) as a function of
ge of Larmor frequencies due to the existence of spin-spin
d to a lower frequency than that of water due to the increased
. To achieve fat suppression, a frequency-selective rf pulse (Chemical
id population, causing saturation of the lipid magnetisation. The
e fat suppression pulse (Figure 2c). In (b) two axial slices acquired
with (bottom row) fat suppression.
Figure 6 (a) A schematic diagram of a cine tagging pulse sequence. In this example a composite binomial rf pulse is used consisting of
three rf pulses with amplitudes in the ratio of 1:2:1. Two modulating gradients are applied in the spaces between the rf pulses to de-phase
(modulate) the transverse magnetisation between each rf pulse. The net effect is to cause a variation (or modulation) of the z-magnetisation,
creating a series of parallel lines of tissue with a magnetisation that varies alternately between its equilibrium value (untagged) and zero (tagged).
A spoiler gradient, S, is applied to destroy transverse magnetisation generated by the tagging pulses. T1 relaxation causes the magnetisation of
the tagged lines to recover towards equilibrium, while at the same time the magnetisation of the untagged tissue becomes partially saturated by
the rf pulses applied as part of the cine imaging sequence. This causes the contrast between the tagged and untagged lines to reduce as the
cardiac cycle progresses. The two short-axis images in (b) are acquired from separate tagged cine acquisitions with tagging applied in two
different directions. The arrows indicate the direction of the modulating gradient in each case. Both image examples correspond to a cardiac
phase at around end-systole. For stationary tissue, such as in the chest wall, the tagged pattern has remained fixed and is seen as a series of
parallel lines. Within the left ventricle, the line pattern has deformed as it follows the motion of the myocardial muscle.
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image slice. The tagging preparation scheme is applied
immediately after the R-wave (at end diastole) and
superimposes a pattern across the image slice consisting
of lines of tissue where the magnetisation is alternately
saturated or at equilibrium (Figure 7). This is commonly
referred to as tagging or spatial modulation of magnet-
isation (SPAMM). The simplest tagging pulse consists of
two rf pulses either side of a single modulating gradient
[37]. The addition of more rf pulses and modulating gra-
dients makes the line pattern sharper [38]. Immediately
after the tagging preparation scheme, a cine image data
acquisition is then performed using a fast cine gradient
echo pulse sequence to readout the signal at multiple
time points throughout the cardiac cycle.
On the first image of the cine series (immediately
after the tagging pulse), the magnetisation pattern
appears as a series of low-signal-intensity parallel lines
across the image where the magnetisation has been
saturated. As the heart contracts through systole the
magnetisation pattern deforms as it follows the contrac-
tion of the myocardial muscle (Figure 6b). As the pat-
tern is generated through saturation of the tissue
magnetisation, T1-relaxation causes the magnetisation
to return towards its equilibrium value. At the same
time the tissue magnetisation at equilibrium becomes
partially saturated by the rf pulses applied as part of
the cine imaging sequence. These two effects cause the
magnetisation of the tagged and untagged tissue toconverge, resulting in a rapid loss of contrast for the
tagged lines and fading of the tagging pattern during
the cardiac cycle. The rate at which contrast is lost can
be reduced by ensuring a low flip angle is used for the
cine gradient echo pulse sequence, and by limiting the
number of cine frames. Typically two line patterns are
generated at right angles to form a grid pattern [38].
This can be done by using two tagging preparation
pulses within the same acquisition (known as grid tag-
ging), or by performing two separate acquisitions with
line tagging at right angles, and subsequently combin-
ing the two data sets as a post-processing step.
SPAMM is the most well established of the methods
used to perform CMR tagging and it is derivatives of this
basic method that are implemented by the MR vendors
for use in routine clinical practice, with visual assess-
ment being the main method of analysis. There have
been many further developments of CMR tagging tech-
niques in the research domain, together with methods
used to analyse the tagged images, and many of these
are described in the recent review [13].
Using exogenous contrast agents to modify contrast
MR Contrast Agents
MR contrast agents work by modifying the tissue proper-
ties that most directly affect image contrast appearances,
namely the T1 and T2 relaxation times. The most
commonly-used contrast agents exploit a property of the
lanthanide ion gadolinium (Gd) known as paramagnetism.
Figure 7 This diagram shows how a SPAMM pulse can produce a magnetisation pattern consisting of a series of parallel lines that are
alternately fully magnetised and fully saturated, appearing as bright and dark lines (shown on the right). In this example, the composite
rf pulse is a 1-2-1 binomial pulse, consisting of three rf pulses with relative amplitudes in the ratio of 1:2:1. As the effective flip angle of the
composite pulse is set to be 90°, the flip angles of the three individual rf pulses is therefore 22.5°, 45° and 22.5° respectively. Starting at
equilibrium (a), the first rf pulse causes all spins to flip through 22.5° (b). The first modulating gradient is then applied causing the spins to move
out of phase along the gradient until there is a 180° phase shift between points that correspond to the desired spacing between adjacent bright
and dark lines. The second 45° rf pulse is then applied, causing the magnetisation that is 180° out of phase to be flipped from −22.5° to +22.5°,
while magnetisation that is in phase is flipped from +22.5° to 67.5° (d). The second modulating gradient introduces a further 180° phase shift
between adjacent bright and dark tag lines (e). The third 22.5° rf pulse is then applied. This causes the magnetisation that is 180° out of phase to
be flipped from −22.5° to 0 (aligned along the z-axis), while magnetisation that is in phase is flipped from 67.5° to 90° to become saturated (f).
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electrons in the outer shell of a metal ion, which cause
it to become temporarily magnetised when in an exter-
nally applied magnetic field creating local magnetic
fields over a short range. Gadolinium is particularly
strongly paramagnetic as it has seven unpaired electrons
in its outer shell, the most of any element. Local field
interactions between the unpaired electrons of the Gd
ion and the hydrogen nuclei within adjacent water
molecules cause a reduction in both the T1 and T2 of
the surrounding tissue. In order for this naturally toxic
element to be suitable for use in human subjects, the
Gd ion is bound or chelated to a larger electron-donating
molecule or ligand. This renders the gadolinium safe for
in-vivo use in most circumstances although gadolinium-
based contrast agents are contraindicated for use in
patients with impaired renal function due to their associ-
ation with nephrogenic systemic fibrosis (NSF) [39-41].
The ability of a given contrast agent to influence relax-
ation rates is expressed in terms of its relaxivity which is
the change in relaxation rate per unit concentration
expressed in mM-1 .s-1. The higher the value of the relax-
ivity, the greater is the T1-reducing effect of the contrast
medium. If the concentration in mM of contrast agent is
C and the T1 relaxivity is r1 then the observed relaxationrate of the tissue T1 (observed) can be related to its native re-
laxation rate T1(native) as follows:
1=T1 observedð Þ ¼ 1=T1 nativeð Þ þ r1  C
There is a corresponding expression for the observed
T2 relaxation rate of the substance T2 (observed) as fol-
lows:
1=T2 observedð Þ ¼ 1=T2 nativeð Þ þ r2  C
Where r2 is the T2 relaxivity and T2(native) is the native
relaxation rate. Relating T1(observed) to the final image sig-
nal intensity (SI) value is more complicated. SI is
dependent on T1, T2, proton density, the MR imaging
sequence and its parameters. Figure 8 describes a typical
plot of SI versus contrast agent concentration. At low
concentrations T1 shortening is the dominant effect of
the contrast agent so that the SI increases with increas-
ing concentration. However at higher concentrations the
T2 shortening effect becomes dominant and SI begins to
fall due to the reduction of T2 to very low values. If the
purpose of the administered contrast agent is simply to
enhance certain structures in the image, as in MRA
investigations (see later), then the administered dose is
designed to maximise the SI and seeks to produce an in-
Figure 8 The relationship between signal intensity and
concentration. Signal intensity values over a range of
concentrations for a spoiled gradient echo pulse sequence. The two
dashed curves show the separate dependencies of the signal
behaviour for T1 or T2 alone. The solid line shows the combined
effect of T1 or T2 on signal intensity. At low concentrations the
effect of T1 shortening is dominant, while at higher concentrations
the T2 shortening effect becomes the dominant factor. A series of
samples imaged with increasing percentage concentrations of
Gadolinium are shown underneath the plot as a visual
demonstration of the effect.
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Figure 8. However if the images are to be used for quan-
titative analysis then the contrast-induced changes in SI
must directly reflect changes in Gd concentration. At
low concentrations this assumption holds because the
relationship between SI and Gd concentration is ap-
proximately linear. At higher concentrations this rela-
tionship becomes non-linear and quantitation of
concentration based on uncorrected SI values will yield
erroneous results. This is often referred to as signal sat-
uration in quantitative MRI, not to be confused with the
saturation of magnetisation caused by the 90o pulse that
generates signal in MRI. It is more helpfully described as
a non-linearity effect, generated by a breakdown of the
assumption that Gd concentration and SI are linearly
related. This is discussed in more detail in the next
section.
Extra-vascular, extra-cellular contrast agents are most
commonly used in clinical practice. These agents are
small enough to leak through the capillaries from the
vascular space into the extra-vascular, extra-cellular
space but not through cell membranes. It is this property
of the contrast agent that enables late gadolinium en-
hancement of myocardial infarcts where the extravascular,extracellular space is enlarged (see later). Intravascular
contrast agents, which stay within the vascular space,
are less commonly used but may be preferable for quan-
titative perfusion imaging as they allow simpler math-
ematical models to be used for flow quantification as no




Myocardial perfusion imaging assesses the blood supply
to the myocardium and plays an increasing role in the
diagnosis of ischemic heart disease [43]. In this section
dynamic contrast enhanced MRI (DCE-MRI) is intro-
duced and the challenging requirements for performing
it in the heart are described with reference to pulse
sequences described in previous sections. A discussion
of the necessary trade-offs that should be considered
when designing a perfusion imaging protocol is given.
Finally quantification of myocardial blood flow (MBF)
from perfusion DCE-MRI datasets is discussed consider-
ing the further imaging constraints required for this
purpose.
Dynamic Contrast Enhanced MRI (DCE-MRI)
In order to assess myocardial perfusion, blood passing
into the myocardium needs to alter image signal inten-
sity so that areas of reduced perfusion can be detected.
This is typically achieved using a signal enhancing con-
trast agent. The contrast agent is injected intravenously
whilst multiple images of the heart in the same anatom-
ical position and the same point in the cardiac cycle are
acquired in successive heart beats. Typically short-axis
images are acquired but a long axis image is also some-
times additionally acquired in order to cover the apex of
the heart. In general the acquisition of a dynamic series
of MR images during the passage of contrast agent
through the body is known as dynamic contrast
enhanced MRI (DCE-MRI) [44]. As DCE-MRI generates
a movie showing the passage of contrast agent through
the body there is a compromise between spatial require-
ments (i.e. coverage, resolution) at each time point and
the temporal requirements (i.e. time interval between
successive frames). For myocardial perfusion imaging
(MPI), the need to minimise the effects of cardiac mo-
tion adds further constraints, making this application of
DCE-MRI one of the most challenging. In the ideal case,
the dynamic series of images, when viewed as a movie,
should be able to demonstrate a motion-free cross-sec-
tion of cardiac tissue whose signal intensity rises and
falls over time as the bolus of contrast agent passes
through the myocardial tissue (Figure 9).
The essential requirements of a DCE-MRI cardiac per-
fusion imaging sequence can therefore be summarised
Figure 9 Dynamic contrast enhanced cardiac perfusion imaging. Contrast agent is injected intravenously whilst multiple images of the heart
are acquired to create a movie showing the contrast agent passing through the heart. Contrast agent can be seen as signal enhancement in the
right ventricular cavity (RV) followed by the left ventricular cavity (LV) and more gradually in the myocardium, before finally washing out.
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within a single heart beat and the effects of cardiac and
respiratory motion must be minimised. In addition the
image contrast must be T1-weighted to maximise the ef-
fect of the contrast agent on image signal intensity. In
order to fulfil these requirements, the choice of pulse se-
quence, method of contrast generation and approaches
to minimise motion effects must be carefully considered.
Choice of acquisition pulse sequence
In DCE-MRI the image appearance changes significantly
between contiguous frames due to the passage of the
contrast agent through the heart so multi-shot k-space
imaging strategies that fill k-space over multiple cardiac
cycles [1] are not applicable. Therefore, in order to ac-
quire images quickly, DCE-MRI perfusion imaging is
generally performed as a single shot technique with a
fast (or turbo) spoiled gradient echo (FGE), balanced
steady state free precession (bSSFP), or echo planar im-
aging (EPI) pulse sequence. All three sequences are fast,
having a very short TR partly by virtue of the fact that
they avoid the need to wait for remnant transverse
magnetization to decay after read-out of the MR signal
echo. Both the bSSFP and the FGE sequences are
described in more detail in part 1 of this review [1]. The
bSSFP sequence ‘rewinds’ the signal de-phased by the
applied gradients by applying additional balancing gradi-
ents to re-phase the MR signal before each subsequent
rf pulse. The remnant transverse magnetization is then
superimposed onto the magnetization generated by sub-
sequent rf pulses, generating high signal from fluid and
blood. Conversely the FGE sequence uses spoiler gradi-
ents to destroy remnant transverse magnetization after
each readout. EPI uses rapidly alternating frequency en-
coding gradients, interspersed by phase encoding pulses,to refocus multiple gradient echoes following a single rf-
pulse. Single-shot EPI acquires all of the echoes required
to fill k-space in a single echo train, however T2* decay
throughout the echo train causes the images to be heav-
ily T2*-weighted, resulting in relatively poor image qual-
ity. For cardiac imaging a hybrid-EPI (also known as
segmented EPI) approach is typically employed where a
number of shorter echo trains are acquired by applying
multiple rf pulses (Figure 10). This reduces the detri-
mental effect of T2* weighting, improving the image
quality while maintaining some of the speed advantage
provided by the EPI technique.
Despite numerous comparison studies there is still no
consensus on the optimal data acquisition pulse se-
quence for perfusion imaging. Objective measures of
pulse sequence performance include the speed of acqui-
sition, the level of artefact and two commonly-used mea-
sures of image quality, signal-to-noise ratio (SNR) and
contrast-to-noise ratio (CNR). Specifically, SNR is the
ratio of the signal intensity of a particular tissue to the
background image intensity in a area where signal is ab-
sent, while CNR is the ratio of the signal difference be-
tween two paricular tissues and the background image
intensity. As FGE uses a rf-pulse per read-out line it is
less susceptible to fluctuations in k-space, which should
theoretically make it less susceptible to ghosting arte-
facts. Nevertheless, hybrid EPI has been shown practic-
ally to be less artefact prone the FGE [45]. Hybrid-EPI is
also faster, allowing increases in coverage and resolution.
By maintaining steady state transverse magnetisation in
bSSFP sequences generate the greatest signal of the
three methods [46]. The higher SNR of bSSFP images
allow a much higher bandwidth to be selected leading to
shorter TE and TR making SSFP a faster sequence than
FGE [1]. SSFP has been shown to have better sensitivity
Figure 10 Pulse sequence diagram for hybrid Echo planar imaging (EPI). In echo planar imaging (EPI) multiple lines of k-space are rapidly
acquired following a single rf excitation pulse. The slope of the frequency encoding gradient is rapidly alternated, generating a train of gradient
echoes. A phase encoding gradient ‘blip’ is applied between each frequency encoding gradient to ensure each gradient echo fills a different line
of k-space. Single-shot EPI acquires all the lines of k-space following a single rf pulse. More commonly in cardiac MR applications, a hybrid or
segmented EPI approach is used where multiple rf pulses are applied each followed by a shorter echo train. In this example, an echo train length
(ETL) = 5 is used.
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image SNR and CNR. However of the three sequences
SSFP is the most prone to artefacts [15] caused by off
resonance magnetization. It has a greater occurrence of
susceptibility artefact and ghosting and is prone to Gibbs
ringing in the endocardium due to the increased differ-
ence in signal intensity between the blood and the myo-
cardium [16]. Explanations of these artefacts are given
elsewhere [48,49]. Due to the large number of causes of
artefacts with bSSFP it tends to be the least robust se-
quence, being both capable of producing high quality
images but prone to significant image artefacts. Table 2
summarises the advantages and disadvantages of the
three sequences.
Use of preparation pulses for T1-weighting
DCE-MR images should be T1-weighted in order to
maximise the effect of the contrast agent on signal in-
tensity. To reduce acquisition time the FGE and seg-
mented EPI sequences described above employ small flip
angles and very short TRs resulting in poor T1-contrast,
while the bSSFP sequence using a higher flip angle is
weighted by the ratio of T2/T1. For this reason a prepar-
ation pulse is applied prior to the read-out pulseTable 2 Comparison of the properties of the pulse
sequences most commonly applied to cardiac perfusion
DCE-MRI
 -More Less -!
Signal bSSFP hybrid EPI + FGE
Speed hybrid EPI SSFP FGE
Artefact Free hybrid EPI FGE bSSFP
The table compares the main data acquisition sequences used in myocardial
perfusion imaging: balanced steady state free precession (bSSFP), hybrid echo
planar imaging (EPI) and fast gradient echo (FGE) in terms of their signal
strength, acquisition speed and propensity for image artifacts.sequence with a sufficiently long preparation pulse delay
to establish a high T1-contrast before the read-out se-
quence is employed. Currently perfusion imaging is usu-
ally carried out using a saturation recovery preparation
pulse as inversion recovery increases the total scan time,
and is more vulnerable to R-R variation [15].
Reduction of cardiac and respiratory motion effects
In perfusion imaging each single-shot image acquisition
is acquired quickly enough to avoid the detrimental ef-
fect of cardiac motion on each individual image. How-
ever, respiratory motion still causes mis-registration
between adjacent temporal frames. It is typically dealt
with by patient breath-holding as the requirement to ac-
quire a dynamic series of images in contiguous heart
beats rules out other methods such as respiratory gating.
ECG-triggering is also still required to ensure that data
acquisition for each image slice is performed at the same
point in the cardiac cycle in successive heart beats so
that cardiac motion appears frozen when the images are
viewed as a dynamic movie.
Figure 11 summarizes the image data acquisition pulse
sequence choices described for perfusion imaging. Once
the pulse sequence has been chosen there are a range of
further factors to be considered when choosing the im-
aging parameters for myocardial perfusion DCE-MRI:
For visual analysis of perfusion defects the T1 weight-
ing can be optimised to maximise T1 contrast during
the passage of contrast agent through the myocardium.
However, if the same image data is to be used for quan-
titative assessment of myocardial blood flow (MBF), the
T1-weighted contrast that is ideal for visual analysis
introduces non-linearity in the relationship between the
signal intensity and the higher concentrations of the Gd
contrast agent found in the blood pool, leading to
errors in the quantitation of MBF. For the detection of
sub-endocardial perfusion defects there is a requirement
Figure 11 Choice of imaging pulse sequence for myocardial perfusion MRI. Diagram illustrating the choices of data acquisition pulse
sequence for myocardial perfusion MRI. A saturation recovery preparation pulse is employed to ensure T1-weighting followed after a delay by the
image data acquisition pulse sequence. The most common data acquisition pulse sequences used are fast/turbo spoiled gradient echo (FGE),
balanced steady state free precession (bSSFP) or hybrid (or segmented) EPI. The number of slices that can be acquired (in this case three) is
limited by the R-R interval, the saturation delay and the length of data acquisition period.
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quisition time for each slice which renders the acquisi-
tion more prone to cardiac motion and limits the
number of slices that can be acquired within a heart-
beat, thus limiting coverage of the left ventricle. As the
acquisition of sufficient slices to cover the whole heart
is desirable, this could be achieved by acquiring an
increased number of slices over more than one heart
beat, but this increases the time between acquisition of
successive images in the dynamic series. For quantita-
tive imaging in particular, it is important to achieve a
temporal resolution equal to the acquisition of an image
every heart beat. Consideration also needs to be given
to the time point in the cardiac cycle that the image
data for each is acquired.
These competing factors must be balanced in order to
create the ideal pulse sequence for the specific purposes
of the study they are being acquired for.T1-weighting and TS
T1 weighting is controlled by careful selection of the sat-
uration time (TS). Typically each imaging slice is
preceded by a preparation pulse so that there are as
many preparation pulses as there are slices in a given
RR-interval. To maximise T1-contrast for visualisation
of perfusion defects within myocardium longer satur-
ation times should be used. However unnecessarily long
TS values take up too much of the RR-interval and limit
coverage (by restricting the number of slices that may be
acquired) and/or spatial resolution (by limiting the
length of the data acquisition per slice). Furthermore if
the images are to be used for quantitative imaging
shorter TS values are preferable to minimise the non-
linearity in the relationship between CA concentration
and signal intensity (See later). A typical TS for cardiac
perfusion imaging is around 100 ms, but a wide range of
values have been used for the reasons described above.
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Image degradation by cardiac motion is dealt with, as far
as possible, by limiting the image data acquisition window,
so the use of ECG triggering serves only to determine at
what phase of the cardiac cycle the heart will be imaged.
This is set by the trigger delay (TD), which is the time from
the ECG R-wave to the time of the acquisition of the cen-
tral line of k-space, ko, (Figure 12). In a single slice acquisi-
tion this can be set to any point of the cardiac cycle. TD
does not change with RR interval so if the heart rate
increases during imaging the cardiac phase of the image
will change during imaging. For long trigger delays, if the
heart rate increases substantially then the next R-pulse
may occur during the image data acquisition so that part
of the image data is acquired from the next heart beat and
the true data acquisition for that beat is skipped. The fast-
est heart motion is during systole and early diastole, thus
imaging at mid-diastole should minimise motion artefacts.
Conversely there is a preference for imaging in systole if
quantitative analysis is foreseen, as the thicker myocardial
wall in systole allows larger ROIs within the myocardium
and subsequently improved SNR in contrast uptake curves.
Coverage and resolution
Endocardial perfusion defects may occur at any point in
the left ventricular wall and so maximising the coverage of
the left ventricle is important. The AHA recommend thatFigure 12 Trigger Delay and Saturation Time. The trigger delay (TD) se
acquired within each RR-interval . The saturation time (TS) determines the
controlling the T1-weighted contrast of the image for a particular image slthree short-axis slices are acquired to cover basal, mid and
apical regions of the left ventricle [50] and that a spatial
resolution of at least 2.5 mm [51,52] is necessary to be able
to reliably detect sub-endocardial defects. The achieve-
ment of all of these requirements within a single RR-
interval is challenging. One approach to increase coverage
along the long axis of the left ventricle is to acquire an
increased number of slices over 2 RR-intervals, which has
the effect of decreasing the temporal resolution of the dy-
namic series. This is a less desirable option if quantitative
assessment of perfusion is required [15,51]. A further al-
ternative is to abandon the requirement that each read-
out pulse has a separate preparation pulse [53]. The delay
following the saturation pulse, TS, is the longest time delay
in the sequence and so the use of a shared saturation pulse
applied to all three slices, followed by three slice data
acquisitions reduces the acquisition time significantly
(Figure 13). However, this approach necessarily results in a
different TS value for each slice. Consequentially, the slices
have differing image contrast, with the shorter TS value
slices being more suited to quantitation as they are less
affected by non-linearity effects, while the slices with
longer TS values are more suited to visual analysis.
Myocardial perfusion image analysis
The most common method of reporting myocardial per-
fusion datasets is by visual analysis of the dynamic seriests the point within the cardiac cycle that the centre of k-space, k0, is
time between the saturation pulse and the centre of k-space, thereby
ice.
Figure 13 Choices for myocardial perfusion imaging – prep pulse scheme and number of slices. With a single slice acquisition per RR
interval (top) there is flexible choice for the optimal cardiac phase and T1-weighted image contrast, but poor coverage of the LV. For multiple
slice acquisitions, the use of a separate preparation pulse for each slice (centre) allows the same image contrast for each slice (fixed TS) but the
two slices are acquired at different cardiac phases due to their different trigger delays and the number of slices is limited (two in this case). Using
a pre-pulse shared by all the slice acquisitions (bottom) potentially allows more slices to be acquired (three slices in this case), but leads to each
slice having both a different T1-contrast behaviour, as each slice has a different (TS), and a different trigger delay.
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transiently as areas of relative reduced signal intensity
are taken to be due to a physiologically significant reduc-
tion to myocardial blood flow and recorded as a ‘perfu-
sion defect’ (See Figure 14 and Additional file 1).
Alternatively quantitative and semi-quantitative mea-
surements of myocardial blood flow (MBF) have been
shown to be useful in the diagnosis of ischemic heart
disease [54-56].
Factors relevant to quantitation of myocardial blood flow
Methods for quantitative analysis of perfusion data have
been reviewed in detail elsewhere [51,57]. In brief regions
of interest are drawn on each frame of the dynamic series
of images to define the myocardium and an area within
the left ventricular blood pool. Signal intensities for each
of these regions are then plotted at each time point to
generate dynamic uptake curves. The blood pool curve is
taken to represent the contrast agent passing into themyocardium or the arterial input function (AIF) and the
myocardial region represents the contrast agent
remaining within the myocardium (Figure 15). These
curves are then analysed in order to estimate MBF.
Semi-quantitative analysis uses a specific property of
the time-intensity curve, such as peak height or max-
imum upslope, as an index of MBF and has been shown
to be diagnostically effective [54,55]. Quantitative methods
aim to derive an absolute MBF value in ml/min/g by fit-
ting the curves to a mathematical model describing the
flow of contrast agent through the myocardium [51,56].
Non-Linearity effects at high Gd concentrations
If perfusion data are to be used for MBF quantitation then
an extra consideration becomes relevant in terms of the
MR acquisition. The non-linearity in the relationship be-
tween gadolinium concentration and signal intensity (SI)
must be minimised. Typically for perfusion measurements
contrast agent doses do not exceed 0.1 mmol/kg and so
Figure 14 Myocardial Perfusion defect. Under stress conditions
an area of reduced signal intensity is observed in the septal and
anterior walls of the left ventricle, consistent with disease in the
coronary arteries supplying these regions. Image courtesy of John
Greenwood [43]. (See Additional file 1 for perfusion movie).
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from T2 shortening (Figure 8). Figure 16 illustrates how
the non-linearity in the relationship between signal inten-
sity and Gd concentration causes blunting of the AIF peak
when plotting signal intensity versus time, yielding under-
estimates in MBF. The degree of.
Nonlinearity depends on the dose and injection rate of
the administered contrast agent, the type of MR pulse
(EPI, FFE, SSFP) and the saturation time (TS).
Acquisition protocols for quantitative perfusion im-
aging attempt to optimise these factors to ameliorate the
effect of this non-linearity on the MBF estimate. The
simplest method is to simply administer a low dose of
contrast agent so that the relationship between MR sig-
nal intensity and Gd concentration is in the approxi-
mately linear region (Figure 16). Contrast agent doses
need to be around 0.01 mmol/kg to ensure linearity in
the blood pool [58]. These low doses reduce the CNR
and SNR of the images rendering visual analysis (still the
main-stay of clinical reporting) difficult. The myocardial
curve enhances less dramatically than the AIF due to the
lower concentration within the myocardium and such
low administered doses can reduce the change in signal
in the myocardium to such an extent that MBF esti-
mates become significantly affected by image noise,
compromising the precision of the MBF estimate.
Approaches that try to overcome these issues include
mathematical conversion of SI to CA concentration
[59,60], dual bolus strategies that repeat the experimentusing low contrast and high contrast doses [61,62], and
dual sequence strategies that repeat the experiment
using two pulse sequences optimised for the blood-pool
and myocardial curves [63].
The dark rim artifact (DRA)
All MR images are susceptible to image artifacts. However
in cardiac perfusion imaging the dark rim artefact (DRA)
is particularly troublesome as it mimics the very perfusion
defects that the investigation is designed to show. DRAs
manifest as transient signal voids at the endocardial
boundary and are easily mistaken for genuine sub-
endocardial perfusion defects. They differ from genuine
hypoperfusion events in that they typically last only a few
heart beats [64] and they can cause the myocardial signal
intensity to drop below the baseline (pre-contrast) signal
value [65]. A number of comparison studies have been
conducted to investigate which sequences are most prone
to DRAs [46,47,66] showing that bSSFP is the acquisition
sequence most affected. The cause of a given DRA is diffi-
cult to pinpoint as multiple factors have been shown to
contribute. Motion during image acquisition can generate
abrupt discontinuities in k-space which translate into
banding artifacts at tissue boundaries in the image [67].
Magnetic susceptibility effects may also cause DRA due to
increase magnetic field distortions around boundaries in
the image and temporal changes in magnetic susceptibility
on the arrival of contrast agent [47,65]. This effect is most
prominent in bSSFP due to its higher sensitivity to
changes in magnetic susceptibility which cause local
changes to the Larmor frequency. These so-called off-
resonance effects become worse at stronger concentra-
tions of contrast agent. The presence of truncation artifact
at the high contrast boundary between the blood pool and
myocardium is another potential cause of DRA [52]. This
is caused by an insufficient content of high spatial fre-
quency data in k-space which means that the Fourier
transform is unable to accurately represent true high con-
trast boundaries in the image. This causes signal variations
adjacent to these boundaries that appear as bright and
dark bands. This effect becomes worse at higher contrast
levels such as with higher bolus concentrations and in-
jection rates, and when using bSSFP as the acquisition
sequence. The most reported potential causes and
minimization strategies of DRA are summarized in Table 3
although a number other causes have been proposed
[15,16]. For a comprehensive and highly informative re-
view of the causes of DRAs see [16].
Delayed imaging after contrast administration
Delayed Gadolinium Enhancement (DGE) imaging is
one of the principal CMR techniques. It has been exten-
sively validated, both in animal models and in clinical
studies [68-70]. The technique itself is remarkably
Figure 15 Quantitative Perfusion Data. For every image in the dynamic sequence region-of interest contours describing the myocardium and
a region in the blood pool are drawn. The mean signal intensity from within each region is plotted for each time point to generate plots of
signal intensity versus time to show the increase in signal intensity in both the myocardium (green) and the blood pool (red). The blood pool
curve is also often referred to as the arterial input function (AIF). These curves can be analysed together to give an estimate of myocardial blood
flow (MBF).
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of gadolinium-based contrast agent followed by the ac-
quisition of T1 weighted images of the myocardium
using an inversion recovery technique. DGE imaging is a
powerful tool for the assessment of a wide and still
expanding range of cardiac pathologies, from acute andFigure 16 Non-linearity effects cause errors in MBF. The left hand grap
between signal intensity and Gd concentration (dotted line) and the true r
relationship at higher concentrations can propagate into a peak height err
causing an overestimate in MBF.chronic myocardial infarction, through inflammatory or
infectious myocardial diseases, to cardiac neoplasms
[71,72].
Depending on the timing of the acquisition relative to
contrast administration, there are two distinct subtypes
of the DGE imaging: Early Gadolinium Enhancementh shows the difference between the assumed linear relationship
elationship (solid line). The right hand graph shows how the non-linear
or in the measured blood pool curve (the arterial input function or AIF)
Table 3 Causes and solutions of DRA
Artifact Description Solution





a) Increase number of phase
encoding lines with
increased image time.
b) Use parallel imaging, with
decreased SNR
Susceptibility Increased magnetic field
distortions at boundaries
and due to arrival of CA
cause signal loss and
voxel mismapping
a) Avoid bSSFP
b) Decrease CA concentration
Motion Discontinuities in k-space
due to motion translate
to banding at boundaries
in the image.
a) Use sequential k-space
ordering.
b) Use parallel imaging
Figure 17 Schematic illustration of an extracellular Gd- based
contrast agent kinetics within the myocardial tissue. Following
intravenous administration, the extracellular Gd-based contrast agent
enters the microvascular network of the myocardium via arterial
inflow (left). It is extravasated into the interstitial fluid (extravascular
extracellular space) and gradually washed out back into the venous
outflow (right) and removed from the body via glomerular filtration.
Areas with an increased volume of interstitial space will present a
larger distribution volume for the incoming contrast agent, but
importantly pathological tissues such as myocardial scar, may also
display slower extravasation rates as well as delayed re-absorption
(wash out) of contrast agent into the vascular space.
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two sub-types of DGE are essentially the same, but the
timing of the acquisition (ta) following intravenous ad-
ministration of the contrast agent (0.1 to 0.2 mmol/kg of
an extravascular gadolinium chelate) is a distinguishing
factor that influences image contrast and provides
insights into different aspects of myocardial pathology.
Whilst typically ta ~ 5 min post injection is used for
EGE, ta > 10 min is used for LGE.
Before describing the nature of temporal changes in
longitudinal relaxation time T1 within LV blood and
normal and pathological myocardial tissue following
intravenous contrast administration, a brief outline of
the use of the DGE technique in its primary setting
(characterization of myocardial scarring after myocardial
infarction) is presented. Temporal changes in T1 and
associated changes in signal intensity in inversion recovery
T1-weighted images acquired at different times post- in-
jection will then be illustrated using a generalised model
of different tissue compartments in DGE studies.
Viability imaging
The identification of scarred myocardial tissue in patients
with acute or chronic myocardial infarction is one of the
most important clinical applications of CMR. This method
is referred to as “viability imaging” as the absence of scar
indicates that the myocardium is viable, i.e. that it retains
a capacity to recover contractile function following revas-
cularisation. The information on the location and the ex-
tent of myocardial scaring is therefore important for
planning coronary artery revascularisation. As the size of
scarred myocardium and its location relative to the endo-
cardial border are important predictors of the potential
for functional recovery [73], CMR assessment of myocar-
dial viability by DGE has an inherent advantage over other
imaging methods (such as PET, SPECT and echocardiog-
raphy) due to its superior spatial resolution.In addition to the identification of the location and the
extent of scarred tissue by LGE, EGE provides important
diagnostic information about the presence and the ex-
tent of microvascular obstruction (MVO). MVO is also
known as the no-reflow phenomenon [74] and its pres-
ence serves as a significant negative predictor of func-
tional recovery post percutaneous coronary intervention
(PCI).
CMR viability assessment is currently conducted by
collecting T1-weighted inversion recovery images of the
myocardium several minutes after a peripheral adminis-
tration of a contrast agent (gadolinium chelate) that se-
lectively alters tissue relaxation times in proportion to
local tissue concentration (see earlier). The local tissue
concentration of exogenous contrast agent changes over
time following bolus administration and the rate of this
change is directly related to several physiological vari-
ables. First, the agent needs to reach the region of inter-
est via systemic and peripheral coronary circulation
(arterial inflow). Next, it is distributed throughout the
myocardial capillary network (Figure 17).
Areas supplied by patent coronary vessels and occu-
pied by a dense capillary network will exhibit strong
enhancement of the MR signal during first pass of the
contrast agent, as the local concentration of contrast
agent carried by blood will cause strong acceleration
of longitudinal relaxation (T1 decrease), and conse-
quent pixel intensity increase on T1-weighted images
(Figure 8).
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time: extravasation of the contrast agent and its accumu-
lation within the extravascular extracellular (interstitial)
fluid. Areas with an increased volume of interstitial space
will present a larger distribution volume for the incoming
contrast agent, but importantly pathological tissues such
as myocardial scar, may also display slower extravasation
rates as well as delayed re-absorption (wash out) of con-
trast agent into the vascular space (Figure 17).
This is why scarred tissue contains high concentrations
of contrast agent compared to normal (viable) myocar-
dium several minutes after bolus administration. It is this
difference in delayed local tissue concentration within
the interstitial fluid that gives rise to image contrast on
what is generally referred to as delayed gadolinium en-
hancement CMR: scarred myocardium appears relatively
hyperintense compared to surrounding viable myocar-
dium on T1-weighted images. This same principle ap-
plies to acute infarction and fibrosis as well as chronic
scar with each appearing bright on LGE images.
To maximise the effect of these differences in contrast
agent concentration, the image readout needs to be
timed to coincide with the point at which the difference
between viable and scarred tissue concentration is most
pronounced and optimal T1-weighting needs to be
achieved to translate these concentration differences into
strong image contrast.
The following sections describe how the changes in
contrast agent concentration affect T1 values of LV
blood, normal myocardium, scar and MVO, and how T1
values change over time. They will also describe the ef-
fect those changes have on MR signal intensity, and how
to achieve image contrast suitable for the delineation of
scar and MVO.
Time-related changes in T1
Although differences in native T1 values between normal
myocardium and regions affected by different patho-
logical processes exist in the pre-contrast state, they tend
to be subtle and difficult to measure using currently
available techniques. Following the administration of an
intravenous contrast agent various tissues experience dif-
ferent degrees of T1 shortening, and the assessment of
these changes in native tissue T1 enables us to distinguish
between normal myocardium and various pathologies.
The differences in the temporal pattern of the return to
the pre-contrast state, and the extent of the SI changes,
give a very powerful (if indirect) measure of the local tis-
sue haemodynamics and water content. Of course, sys-
temic factors could potentially obscure this process of
differentiation and must therefore be taken into account.
Although the exact mechanisms behind the complex
contrast patterns that characterise EGE and LGE in par-
ticular are still not fully understood, it is helpful to try toexplain them in the context of two distinct phases of
extracellular contrast agent pharmacokinetics, namely
early access phase (EGE) and late distribution phase
(LGE). To illustrate the principal contrast-inducing
process (contrast agent induced temporal T1 changes), a
set of measurements adopted from a study by Klein
et al. [75] will be used.
Following bolus injection of T1-shortening contrast
agent, a transient sharp increase in the blood signal (ar-
terial input function peak) is followed by several oscilla-
tions (recirculation peaks) after which a gradual
approach to equilibrium occurs. In the equilibrium the
concentration of contrast agent in the circulating blood
is in balance with the concentration in the interstitial
compartment (Figure 17).
The first phase (access phase) is dominated by the dif-
ferences in microvascular blood supply – the existence
and “quality” of the myocardial capillary network. In
areas where this network is non-existent or disrupted,
contrast agent will have limited access and therefore lit-
tle or no impact on signal intensity. Therefore, following
intravenous injection, contrast agent carried by the
blood will shorten the T1 values in the areas that are
normally perfused, but will have little or no effect on
areas with disrupted or non-existent blood supply, such
as microvascular obstruction or thrombus. In EGE im-
aging (ta ~ 5 min post-injection), all tissues apart from
MVO experience a significant T1 shortening (Figure 18,
second panel from the left).
In areas occupied by MVO, a very modest amount of
contrast agent is present at 5 min post-injection, and the
T1 value within the MVO is high compared to the other
three compartments at this time point.
The rate of recovery towards the baseline (pre-contrast)
T1 value reflects the washout of contrast from individual
compartments. Whilst normal myocardium and LV
blood T1 values continue to rise between 5-15 min
post-injection, scar tissue still maintains low T1 values,
due to delayed extravasation and accumulation of con-
trast agent within an enlarged interstitial water com-
partment (Figure 18). The low values of T1 may further
be maintained by the slow washout kinetics [76].
In MVO, T1 values may continue to decrease, as the
areas occupied by MVO may receive contrast agent via
passive diffusion from the neighbouring scar [77].
Pulse sequences for EGE and LGE
In CMR perfusion imaging signal acquisition needs to be
performed during the first pass of the contrast agent
through the myocardial capillary bed. The contrast agent
concentration changes very rapidly during this time, thus
requiring a dynamic imaging technique using an ultra-
fast single shot acquisition pulse sequence (see previous
section on perfusion imaging). In DGE the signal
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contrast agent kinetics when the concentration of con-
trast agent changes relatively slowly and image data
acquisition over several heart beats using a cardiac-
triggered, multi-shot imaging pulse sequence [1] is there-
fore possible. This means that high spatial resolution
DGE images can be acquired, a factor that is important
for accurate delineation of scar size and especially its
transmural extent.
DGE images are typically acquired using an inversion
recovery, segmented, fast (or turbo) gradient echo se-
quence (IR-FGE) [1]. For each shot, several lines of k-
space are filled within an image data acquisition window
typically limited to 150-200 ms, with a trigger delay cor-
responding to mid-diastole to minimise the effects of
cardiac motion (Figure 19). The cardiac triggering para-
meters are set to acquire image data in every second
heart beat, to allow sufficient signal recovery over 2 RR
intervals. This ensures almost complete recovery of the
z-magnetisation for all tissues with T1 shorter than ap-
proximately 0.4 * RR (i.e. 400 ms for HR= 60 bpm). In
cases of tachychardia or bradycardia, data acquisition
can be spaced in every third or every RR interval, re-
spectively. The main physiological limitation in the
choice of imaging parameters for this sequence is the
length of the breath hold that a patient can comfortably
sustain. This determines the number of RR intervals that
can be used for signal collection, depending on patient’s
HR. Typically 8–10 shots are acquired within 16–20 RR
intervals, and the number of lines of k-space that are
acquired within each individual shot will determine the
resulting spatial resolution for a given field of view. The
number of lines of k-space in each shot is determined by
the operator as the number of views per segment (GE),
turbofactor (Philips) or number of segments (Siemens).Figure 18 Time-course of T1 for EGE and LGE. This shows the time-cou
myocardium following administration of 0.2 mmol/kg Gd-DTPA. T1 values
EGE imaging (ta ~ 5 min post-injection), all tissues apart from MVO experien
occupied by MVO, a very modest amount of contrast agent is present at 5
compared to the other three compartments at this time point. The rate of
washout of contrast from individual compartments. Whilst normal myocard
injection, scar tissue still maintains low T1 values, due to delayed extravasa
water compartment. The low values of T1 may further be maintained by th
as the areas occupied by MVO may receive contrast agent via passive diffuIncreasing this parameter shortens the breath-hold
period at the expense of a longer data acquisition win-
dow, which may lead to motion induced blurring.
With the readout timing limitation (150 to 200 ms)
and a typical TR of 5-10 ms, 15 to 40 lines of k-space
can be acquired within a single data acquisition window.
A typical acquisition matrix is 240 x 240, which yields
DGE images with a voxel size of 1.75 mm, for a FOV of
420 mm.
Each image data acquisition is preceded by a non-
slice-selective inversion recovery preparation pulse to
provide T1-weighting. As well as producing strong T1
contrast, the inversion recovery (IR) technique has the
additional benefit that is it is possible to suppress the
signal from tissue of a particular T1. Careful choice of
the time delay after inversion, TI, allows the optimisation
of contrast between tissues with different contrast agent
concentrations including selective suppression of one of
these tissues. The TI value is either fixed (~440 ms, as in
EGE) or determined empirically for LGE applications
(see next section).
With this choice of timing for the inversion pulse
(Figure 19), the z-magnetisation for the tissue with
longer T1 (red line) will be close to zero at the time of
the readout. The voxels occupied by tissues with this
T1 value will therefore have very low SI on MR images
(i.e. this T1 value will be “suppressed” or “nulled”).
In a typical LGE exam, 10–12 breath hold slices are
acquired in short axis orientation, followed by long axis
and 4-chamber views where clinically indicated. The
choice of TI needs to be periodically updated if the
examination is prolonged to ensure optimal nulling of
the normal myocardial tissue, as the T1 of the normal
myocardium will continue to increase gradually during
this time.rse of the changes in longitudinal relaxation time T1 in LV and
are adopted from the data measured in a study by Klein et al. [75]. In
ce a significant T1 shortening (second panel from the left). In areas
min post-injection, and the T1 value within the MVO is high
recovery towards the baseline (pre-contrast) T1 value reflects the
ium and LV blood T1 values continue to rise between 5-15 min post-
tion and accumulation of contrast agent within an enlarged interstitial
e slow washout kinetics. In MVO, T1 values may continue to decrease,
sion from the neighbouring scar.
Figure 19 Pulse sequence diagram for IR-GRE. Pulse sequence diagram representing two consecutive segments of an IR-FGE sequence used
in early and late Gadolinium enhancement imaging. In a typical breath hold acquisition of a single DGE slice, 8–10 segments are acquired to fill
~192 -240 lines of k-space. The changes in Mz/M0 are illustrated in the middle panel, with green and red lines representing Mz/M0 in short and
long T1 regions. The bottom panel illustrates the changes in signal intensity in the modulus MR images (SI ~ |Mz/M0|). For each shot, several lines
of k-space are filled within an image data acquisition window typically limited to 150-200 ms, with a trigger delay corresponding to mid-diastole
to minimise the effects of cardiac motion.
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The image contrast between different tissue compart-
ments is controlled by choosing an appropriate inversion
time, TI to highlight the differences in their T1 values.
This implicitly highlights the differences between time-
variant concentrations of Gd-DTPA in individual tissue
compartments, as described in the earlier section. As LV
blood pool and scar have very similar T1 values between
5–15 minutes post contrast, their recovery curves closely
follow each other. Separation of scar and blood pool sig-
nal is therefore difficult to achieve. However, an appro-
priate choice of TI will highlight the differences between
MVO and normal myocardium in EGE. In LGE, the TI
can be fine-tuned to emphasize the differences in T1 of
normal myocardium and scar.
Figure 20 illustrates inversion recovery curves in four
tissue compartments using T1 values presented in the
section on time-related changes in T1 (Figure 18). This
figure shows how temporal changes in T1 affect the pat-
terns of SI recovery to equilibrium and shows the im-
portance of choosing the optimal TI to achieve desired
image contrast.
In EGE, the difference between T1 in the MVO com-
partment and surrounding scar and normal myocardium
is emphasized by using a long TI which minimises the
signal from the MVO. In the example presented in
Figure 18, a TI of 440 ms will null the signal from MVO
(T1 = 640 ms at 5 minutes post-injection). With thischoice of TI, surrounding scar and normal myocardium
appear bright, thus enabling identification of MVO
(Figure 20, left panel).
At 10 and 15 minutes post-injection, the differences in
T1 between normal myocardium and scar begin to
emerge due to delayed accumulation of contrast in the
enlarged interstitial space of the scar. To maximise con-
trast between scar and normal myocardium, a TI of
300 ms is chosen to null the signal from normal myocar-
dium at 10 min LGE images (Figure 20, middle panel).
As T1 values continue to change between 10 and 15 min-
utes post injection, the optimal nulling time rises to
320 ms in at 15 minutes post-injection for the example
presented above (Figure 20, right panel).
Overall signal levels continue to decrease during the late
enhancement phase as LV and normal myocardium con-
tinue their return to their pre-contrast (long) T1 values.
In contrast to EGE, where a fixed TI (~440 ms) nor-
mally yields very good contrast between the MVO and
the surrounding scar and normal myocardium
(Figure 21), the TI value needs to be determined empir-
ically in LGE studies. The LGE acquisition is therefore
preceded by a TI-scout module, described in the follow-
ing section.
Selection of TI for optimal LGE imaging – the ‘TI scout’
The main practical difference in the acquisition of EGE
and LGE is that LGE is preceded by a TI-sweep Look
Figure 20 Inversion recovery curves at 5-15mins post-injection. Inversion recovery curves at 5, 10 and 15 minutes post-injection and relative
signal levels obtained by choosing TI values to suppress signal form MVO (purple curves) at 5 minutes post injection and normal myocardium
signal (red curves) at 10 and 15 minutes post-injection. Curves are shown of both the z-magnetisation, Mz expressed as a fraction of the
magnetisation at equilibrium, Mo (Mz/Mo) and the modulus of this value, (|Mz/Mo|), representative of the actual displayed signal intensity. In EGE,
the difference between T1 in the MVO compartment and surrounding scar and normal myocardium is emphasized by using a long TI which
minimises the signal from the MVO. A TI of 440 ms will null the signal from MVO (T1 = 640 ms at 5 minutes post-injection). With this choice of TI,
surrounding scar and normal myocardium appear bright, thus enabling identification of MVO (left panel). At 10 and 15 minutes post-injection,
the differences in T1 between normal myocardium and scar begin to emerge due to delayed accumulation of contrast in the enlarged interstitial
space of the scar. To maximise contrast between scar and normal myocardium, a TI of 300 ms is chosen to null the signal from normal
myocardium at 10 min LGE images (middle panel). As T1 values continue to change between 10 and 15 minutes post injection, the optimal
nulling time rises to 320 ms in at 15 minutes post-injection for the example presented above (right panel).
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sion time TI to null the signal from the normal myocar-
dium and maximize the contrast between normal
myocardium and scar tissue.
The exact value of this parameter will depend on the
individual haemodynamics and systemic water compart-
mentalisation that will define global contrast agent kin-
etics in individual patients. The optimal TI will also
change over time, as T1 values in all four compartments
continue to change. Whilst LV blood and normal myo-
cardium T1 values continue their recovery towards their
baseline (pre-contrast values) during this late enhance-
ment phase, T1 values in scar tissue and MVO follow a
different pharmacokinetic path determined by the vol-
ume of the interstitial space, wash-in and wash-out rates
and, in the case of MVO, passive diffusion of contrast
from the surrounding scar tissue.
For example, the optimal TI that will suppress the sig-
nal from normal myocardium will be 300 ms at 10 min-
utes post-injection in the example presented in
Figure 18, but at 15 minutes post-injection, the optimal
TI will be 320 ms (Figure 20).
As exact values of T1 in individual tissue compart-
ments are not known ahead of IR-GRE acquisition, opti-
mal values of TI need to be determined empirically. In
the T1-sweep Look Locker module, TI values are chan-
ged incrementally before each image readout. The
resulting images display different contrast between the
four compartments, and allow the operator to identify
the TI which best minimises the signal from normal
myocardium.
In the example presented in Figure 22, relative signal
intensities in four tissue compartments are presented as
a function of incrementally changing TI. The image
where normal myocardium appears darkest, identifies
the optimal inversion time (320 ms in the example used
here).Figure 21 EGE images. a) EGE image acquired in the 4-chamber orientati
lateral wall associated with transmural infarction that extends from base alm
transmural scar (arrowheads) that envelops an area of MVO in the lateral wAlternative DGE pulse sequences
Although the standard IR-FGE sequence combined with
a modulus image reconstruction is still the most widely
used in clinical practice, there are other approaches that
aim to address different shortcomings of this standard
approach.
As IR-FGE contrast using modulus reconstruction is
very sensitive to the choice of TI, and small variations in
TI can cause different distributions of signal intensities
in typical modulus images (Figure 20), a pulse sequence
and image reconstruction which can take account of the
sign of the z-magnetisation at the time of data acquisi-
tion was developed to alleviate this problem and increase
the dynamic range of IR signal intensities [79]. This ap-
proach is called Phase Sensitive Inversion Recovery
(PSIR) and the effect that it is designed to produce is
illustrated in Figure 23.
As the polarity of the signal is restored, relative signal
levels between normal myocardium and scar can be cap-
tured over a wide range of inversion times, and precise
estimation of TI via a TI Scout module is no longer
necessary.
As can be seen in Figure 23, once signal phase is
restored, normal myocardium will continue to have low
signal intensity compared to scar over a wide range of
TI values. Relative signal levels for TI ranging from
280 ms through 320 ms (true null point for normal myo-
cardium), to 360 ms are illustrated in Figure 24 below.
By collecting the IR prepared signal in a 3D mode, sig-
nificant savings in imaging time can be achieved [80,81]
However, the required readout window is longer com-
pared to 2D and the spatial resolution is significantly
reduced too. To offset these drawbacks, navigated free-
breathing approaches have been proposed [82,83].
In addition to these efforts directed at collecting DGE
images in a more time-efficient manner, there is an on-
going research into alternative signal preparation schemeson demonstrating a large area of microvascular obstruction in the
ost to the apex (arrowheads). b) Short axis LGE image depicts a
all. Images courtesy of Dr J. Greenwood, MCRC, University of Leeds.
Figure 22 Look-Locker TI scout train. This figure shows the relative signal intensities for the LV blood pool, normal myocardium, scar tissue
and MVO for the images acquired at different TI values using a TI scout (Look-Locker technique). The image where the normal myocardium
appears darkest is identified as the optimal TI time. In this example, TI of 320 ms nulls the signal from the normal myocardium.
Figure 23 Phase sensitive inversion recovery sequence. By using
a phase sensitive reconstruction, the sign of magnetisation is
reflected in the displayed signal intensity. The signal intensity is
mapped onto a grey scale showing values of zero at the centre of
the grey scale, positive values as higher pixel intensities (towards
white) and negative values as lower pixel intensities (towards black).
Using this method, the effect of a small error in the choice of
optimal TI is reduced. The normal myocardial signal can be
suppressed by careful windowing of greyscale.
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mal myocardium, as well as scar and blood [84,85]. With
a wider use of parallel imaging, further refinements in
both DGE preparation and readout are likely to emerge in
the coming years [7].
Magnetic Resonance Angiography (MRA)
In this section, three different approaches to performing
MR angiography will be described. First, the most com-
mon approach, known as contrast enhanced MR angiog-
raphy (CE-MRA) involves the use of a Gadolinium-based
contrast agent to delineate the vessel lumen and is an ex-
tremely fast and reliable method for imaging the vascula-
ture outside the heart. Due to concerns relating to the use
of contrast agents in patients with poor renal function,
there has been a resurgence of non-contrast MRA techni-
ques to image vasculature outside the heart. The exact ap-
proach is dependent upon the vessel to be imaged, but
this section provides a brief overview of the currently
available methods. For all of the above MRA methods,
image degradation caused by respiratory motion within
the thorax and abdominal regions is eliminated by per-
forming the acquisition during patient breath-holding.
However this limits the acquisition time and hence the
spatial resolution of the method. For imaging of the cor-
onary arteries, their relatively small diameter, together
with significant motion during the cardiac cycle, make the
standard MRA techniques ineffective. The final part of
this section describes the most common approach to cor-
onary MRA, respiratory navigator-gated 3D coronaryangiography. This is performed without the use of con-
trast agent over several minutes to achieve higher spatial
resolution. Respiratory motion is compensated for by ac-
curately gating the acquisition with respect to the respira-
tory cycle by using special navigator rf pulses to accurately
track diaphragm position, while the influence of cardiac
motion is removed by using ECG triggering to synchron-
ise the data acquisition to mid-diastole.
Figure 24 Relative SI levels in Phase Sensitive IR sequence. By
restoring signal polarity (Figure 23), normal myocardial signal
remains markedly lower than scar, even if the null point is
underestimated by 40 ms. Note that negative signal intensities
correspond to tissues who’s longitudinal magnetization has not
recovered past Mz = 0 at time TI. For image display purposes, tissues
with zero magnetisation values are mapped onto the middle of the
image pixel intensity range. Tissues with a positive magnetisation
are then displayed with image pixel intensities increasing from this
middle value, while tissues with a negative magnetisation are
displayed with images pixel intensities decreasing from this middle
value. ‘Nulling’ the normal myocardium can then be achieved
retrospectively by adjusting the window and level on the viewing
console and there is no longer an ambiguity between tissues with
positive and negative magnetisation values.
Figure 25 This schematic diagram illustrates the key principles of CE-
in a CE-MRA acquisition. Following the intravenous injection of contrast ag
through the right and left sides of the heart before entering the arterial sys
contrast agent in the arteries and veins within the region of interest over t
is timed to commence after the arrival of the contrast bolus within the arte
in the corresponding venous system (sometimes referred to as the A-V win
intensity relates to tissue type for a typical T1-weighted MRA pulse sequen
introduction of contrast agent, fat tissue would have the brightest signal in
The introduction of contrast agent into the blood reduces its T1 relaxation
during first pass of the contrast bolus through the arterial system must be
so that the arterial vessel lumen yields the highest pixel intensities on the
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The basic principle behind CE-MRA is essentially the
same as that of conventional x-ray angiography: A bolus
of contrast medium is injected intravenously and imaging
is performed during the first passage of the bolus through
the vessels of interest [86,87]. As it is desirable to maxi-
mise the contrast generated by the presence of the con-
trast medium, the aim is to maximise the signal enhancing
effect of contrast medium in the vessels of interest, while
minimising the concentration in the surrounding tissue
and unwanted vessels. The CE-MRA pulse sequence must
therefore be fast enough to be completed within a limited
time window during maximum arterial enhancement and
before venous enhancement, sometimes referred to as the
arterio-venous window (AV) window (Figure 25a).
In order to perform CE-MRA successfully it is import-
ant to understand the practical implications of the above
requirements. The following sections will explain the
basis of choosing the volume and duration of the bolus
injection, timing the image acquisition to coincide with
the first pass phase of the contrast medium and selecting
a suitable pulse sequence and its parameters to provide
a sufficiently rapid data acquisition whilst maintaining
good contrast, 3D coverage and spatial resolution.
The basis of image contrast in contrast-enhanced MRA
(CE-MRA)
CE-MRA relies on achieving a difference between the T1
relaxation value of the blood containing the contrastMRA. The diagram in (a) shows the relative timing of the key events
ent into a subject, there is a delay as the contrast bolus travels
tem. The red and black curves show the variation of concentration of
ime. Optimum image quality is achieved if the image data acquisition
rial system of interest and is completed before the arrival of contrast
dow). The schematic diagram in (b) shows qualitatively how signal
ce. Indicative values for T1 relaxation time are also shown. Without the
the image and blood within the vessel lumen would not be visible.
time and increases the signal intensity. The maximum concentration
sufficient to reduce the T1 of blood to significantly below that of fat,
image.
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the vessels of interest appearing as the brightest structures
on the images. If the difference between the T1 of the
blood and that of the next brightest structure on the
images, (usually fat), is sufficiently great, then the fat and
the other tissues can be eliminated by windowing. This
then allows simple post-processing methods [88], includ-
ing maximum intensity projection (Figure 26 and Add-
itional file 2) to provide images of the vascular tree with
ease. In non-contrast imaging, fat has the shortest T1
value of all the tissues (in the range 170-230 ms depending
on field strength). For standard T1 weighted imaging it
therefore has the highest signal of all the tissues in the
image (Figure 25b). Since, for CE-MRA, a much higher
signal is required from the vessels relative to the other tis-
sues, the concentration of contrast media achieved during
first pass through the vessels must be sufficient to reduce
the T1 value of the blood to well below that of fat. Fur-
thermore, as very short TR values are required to achieve
the fast scan times, it is necessary to lower the T1 value ofFigure 26 Maximum Intensity projection (MIP). This diagram
shows an overview of how projection images can be produced from
multiple slice MRA image data. For 2D acquisitions, multiple thin
overlapping slices are acquired. For 3D acquisitions, the selected
volume is encoded and partitioned into multiple thin, contiguous
slices. The MRA technique and its acquisition parameters are chosen
to produce a signal intensity from the vessels of interest that is
significantly higher than that of the background tissues. The
maximum intensity projection (MIP) is produced using computer
processing software that traces parallel paths through the data in
the direction of the intended projection image, records the
maximum pixel intensity encountered and stores this onto the
projected image. The lateral and A-P views shown are typical of
those produced automatically by the software immediately
following image reconstruction. It is usually possible to also
prescribe automated reconstruction of customized MIPs at any
arbitrary angle. Further MIPs can also be produced retrospectively on
a workstation. A disadvantage of the automated MIPs shown is that
they often contain overlapping vessels and a relatively high signal
from background tissue. This can be removed with interactive post-
processing software so the MIP algorithm is only applied to a
selected volume of data, sometimes referred to as targeted MIP.blood sufficiently to avoid undue saturation of the signal
within the vessels. Typically, for CE-MRA, it is desirable
to achieve T1 values of the order of 50 ms or less.
Conventional T1-weighted anatomical imaging using spin
echo or spoiled gradient echo pulse sequences is achieved
using a short TR and a short TE [1]. For both these techni-
ques, the TR is chosen so that there is good contrast be-
tween most of the tissues, and most of the tissues (apart
from fluid) will contribute a reasonable signal. For CE-
MRA, much shorter TR values are used. In this case, the
signal from all of the tissues, including fat, is significantly
reduced. High signal intensities only exist where the con-
trast medium is present at sufficiently high concentrations.
The concentration of contrast agent during first pass,
cfirst pass required to reduce the T1 of blood to around
50 ms can be calculated using the relationship described
in the early section on contrast agents, which relates T1
relaxation rate to the concentration of contrast agent of
a given relaxivity, r1. For most currently available
gadolinium-based contrast media, the T1 relaxivity is ap-
proximately 0.004 ms-1 mM-1 for field strengths of
1.5 T. Estimating the T1 of blood without contrast agent
as 1200 ms, the required concentration can be estimated
to be around 5 milliMolar (mM).
The original concentration of the contrast medium
(from the bottle) depends on the particular contrast
agent used, but a typical value might be 0.5 mmol/ml.
(=0.5 mol/l = 0.5 Molar concentration), which is about
100 times too high. Once injected, however, the initially
high concentration of contrast medium within the bolus
becomes diluted as it travels from the injection site by
gradual mixing with the blood pool as it travel first
though the right side of the heart, the pulmonary circu-
lation and then the left side of the heart.
By making some assumptions about the physiology of
the patient and that the contrast agent mixes evenly with
the blood pool during the first pass stage, it is possible to
estimate how mixing with the blood pool affects concen-
tration of the contrast medium in the arterial system dur-
ing the first pass for a given injection rate as follows [89]:
Cfirst pass ¼ Cbottle  Injection rate=Cardiac Outputð Þ
where Cbottle is the original concentration of the contrast
medium (from the bottle). For a typical person the cardiac
output is around 6 litres/minute, which is equal to
100 ml/s. Using the above relationship to achieve the
desired dilution of Cfirst pass / Cbottle = 1/100, the required
injection rate must be around 1 ml/s. In clinical practice,
injection rates of between 1–5 ml/s are in use. An increase
in injection rate results in a higher concentration of con-
trast agent during the first pass, further reducing the T1 of
blood and increasing the signal intensity within the ves-
sels. The duration of injection will determine the duration
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sition time of the MR pulse sequence. The injection rate
and the duration of injection together determine the vol-
ume of contrast agent delivered and therefore the dose.
Each of these parameters needs to be carefully balanced to
avoid giving the patient unnecessarily large doses of con-
trast agent, while maximising signal intensity. There is
clearly an advantage in choosing acquisition techniques
that can achieve shorter acquisition times, leading to a
shorter duration of injection and lower contrast dose
without compromising the injection rate.
There is also an effect of the contrast medium upon
the T2 relaxation time, which is determined by the T2
relaxivity, r2. For field strengths from 0.5 to 1.5 Tesla, r2
is approximately 0.006 ms-1 mM-1. If it is assumed that
the T2 of blood without the contrast medium is approxi-
mately 200 ms, then by a similar calculation, the
observed T2 of the arterial blood during first pass is ap-
proximately 28 ms. The T2 of the blood is therefore also
considerably shortened, but not by the same proportion
as the T1. To minimise any signal loss caused by the re-
duction of the T2 value of the blood, the echo time of
the pulse sequence must be kept as short as possible. As
a rule of thumb, provided that the T2 is greater than
two times the TE, signal loss due to T2 effects will not
be significant, except in regions where the concentration
is closer to the original concentration within the injected
vein. This is often seen as signal drop-out within the
vein close to the site of injection.
The CE-MRA pulse sequence
The standard pulse sequence used for CE-MRA is the
spoiled-gradient echo pulse sequence as described in part I
[1] with the vendor-specific names FLASH (Siemens), T1-Figure 27 Comparison of 2D and 3D image acquisition. This diagram s
2D acquisitions (a) a slice is selectively excited, and the MR signal is encod
conventional (not segmented k-space) acquisitions, the acquisition time, T2
and the number of signals averaged, NSA. For 3D imaging (b), a volume (o
phase encoding and frequency encoding as for 2D imaging and additiona
2D imaging, the acquisition time for 3D imaging, T3D, is increased by a fact
selection direction, NS. In practice, NS is greater than expected as more slic
reconstruction. This because the tissue excitation at the edge of the volum
wrap which is analogous to the image wrap experienced in the 2D phaseFFE (Philips) or SPGR (GE). A gradient echo pulse se-
quence is chosen because it is possible to achieve very
short TR values for fast acquisition times and it exhibits
bright-blood contrast in comparison with spin echo based
pulse sequences. Spoiling is used to remove the influence
of steady-state signal from the transverse component of
magnetisation and to ensure T1-weighting. Both the mini-
mum TE and TR are limited by the MR system hardware
performance. The TE must be as short as possible to min-
imise signal from the short T2 and magnetic susceptibility
effects of the contrast medium during the first pass stage.
The minimum TR is the main parameter which deter-
mines the scan time for a given scanning geometry. It is
therefore important to make the TR as short as possible.
CE-MRA is normally acquired using a three-dimensional
(3D) acquisition (Figure 27), where a volume (or thick
slice) of tissue is excited at for each repetition, and then
encoded in three dimensions [27]. In comparison to a 2D
acquisition, a 3D acquisition allows thinner slices to be
reconstructed which are also contiguous. This provides sig-
nificantly improved spatial resolution in the slice direction,
thus improving the quality of the multi-planar reformatting
(MPR) and Maximum Intensity Projections (MIPs). Even
though 3D acquisitions require a substantial increase in
the number of repetitions, the scan times are still relatively
short, because a very short TR is used. The very short TR
also results in increased saturation (signal reduction) of the
background tissue signal, which significantly improves the
quality of the maximum intensity projections.
Key pulse sequence parameters for CE-MRA
The key geometry parameters of a spoiled gradient echo
pulse sequence are chosen to give the best possible
spatial resolution and image quality while providinghows the key differences between 2D and 3D image acquisitions. For
ed in two dimensions by phase encoding and frequency encoding. For
D is determined by the TR, the number of phase encoding steps, NP
r thick slice) is excited and then encoded in three dimensions by
lly by phase encoding in the volume selection direction. Compared to
or equal to the number of phase encoding steps in the volume
es are acquired than specified by the user and discarded after
e is less well defined and these images may also suffer from image
encoding direction.
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ing the acquisition time for patient breath-holding.
Table 4 attempts to illustrate how these conflicting aims
affect the choice of each parameter. In the ideal case it is
desirable to generate both high SNR and high spatial
resolution with a fast scan time. In practice, an improve-
ment in one of these must be traded against the other
two. This can be better appreciated by understanding
the factors that determine SNR.
In general SNR is proportional to the voxel volume
and the square root of the number of phase encoding
steps, while the spatial resolution is directly related to
the voxel dimensions. For a 3D acquisition, the voxel
dimension in the phase encoding direction is equal to
the field of view in that direction divided by the
number of pixels NP in that direction, while the voxel
dimension in the slice encoding dimension (the slice
thickness) is equal to the field of view in that direc-
tion divided by the number of pixels (or slices) in that
direction, NS.
The acquisition time is calculated from the TR the
number of phase encoding steps in each direction, corre-
sponding to the number of pixels and slices thus:
Scan time ¼ TR:NP:NSTable 4 Influence of geometry parameters for CE-MRA acquis
Geometry Parameter How is it chosen? Why?




Increase to 512 preferred
To get best
direction
Acquisition Matrix, NP, in the
phase encoding direction
Maximise To get best
encoding di
(depends on breath-hold period)
No of slices, NS Maximise Increases co
(depends on breath-hold period,
slice thickness and FOVS
Increases SN
(fixed slice t




Field of View (FOVR) Optimise for desired in-plane
coverage




Minimise for desired coverage
in phase encoding direction
Reduces sca
FOVP = RFOVxFOVR (NP reduces
Zero filling/ interpolation Apply in the slice direction Doubles the
slices (but d
This table shows how different geometric parameters can be chosen to improve sp
off reflected in increased scan time or poorer signal to noise ration. Abbreviations a
and slice encoding directions respectively. FOVR, FOVP, FOVS = Field of view in the r
RFOV= rectangular field of view factor. THK = slice thickness.For a given field of view, increasing NP and NS gives
a proportionate improvement in spatial resolution in
each direction, but also increases the scan time in
proportion to the product of the two. In each case
the SNR is also decreased (proportional to the square
root of NP and NS). This is because the increase in
SNR caused by the increased signal sampling (propor-
tional to the square root of the product of NP and NS) is
more than offset by the decrease in SNR caused by the
reduction in voxel volume (directly proportional to
the product of NP and NS).
Given the above constraints the best way to minimise
the acquisition time whilst achieving high spatial reso-
lution is to make the TR, and consequently the TE, as
short as the MR system hardware and software will
allow. The use of low flip angles, described in Part I [1],
together with the reduction of T1 relaxation times by
the use of contrast agent makes extremely short TR
values of less than 5 ms possible.
The flip angle is chosen to maximise the signal for a
particular TR and T1 value (known as the Ernst angle).
In practice flip angle values in the range 30°-40°
which are slightly higher than the Ernst angle are
used to improve the saturation of the background tis-
sues and hence maximise the contrast between them
and the vessels.itions
What is the limitation/ disadvantage?




Increases Scan time (directly proportional)
SNR decreases as square root of increase
verage of volume thickness Scan time (increases proportionally)
R as square root
hickness)
ough-plane resolution Decreases coverage
Decreases SNR (directly proportional)
est in-plane resolution
ing too much foldover
If too small, foldover becomes a problem.
SNR decreases with FOVR (proportional to
square).
n time Foldover is increased
in same proportion as RFOV) SNR is decreased




atial resolution and coverage of the region of interest, together with the trade-
re as follows: NR, NP, NS = Acquisition matrix in the readout (frequency), phase
eadout (frequency), phase and slice encoding directions respectively.
Biglands et al. Journal of Cardiovascular Magnetic Resonance 2012, 14:66 Page 29 of 40
http://www.jcmr-online.com/content/14/1/66Timing of the start of acquisition after contrast injection
Achieving the correct timing of the start of the acquisi-
tion from the time of contrast injection is perhaps the
most crucial aspect of CE-MRA as it strongly deter-
mines the quality of the result. The timing must take
account not only of the acquisition time of the MRA
pulse sequence, but also the order in which the lines of
k-space are acquired during the 3D acquisition (the
k-space order). The central lines of k-space primarily de-
termine the image contrast [1,25]. The timing of the
MRA acquisition must therefore be such that the central
lines of k-space are acquired at the time of highest con-
centration of contrast agent within the vessels of inter-
est. For 3D CE- MRA acquisitions, the two most
common approaches to k-space order are linear, where
the centre of k-space is acquired at the centre of data ac-
quisition and elliptical centric [90,91], where the centre
of k-space is acquired at the start of data acquisition
(Figure 28).
There are two main approaches for timing the start of
data acquisition (Figure 29), based either on a predeter-
mined time delay measured using a small test bolus [92],
or on the real-time monitoring of the contrast agent
entering the region of interest to be imaged using a dy-
namic acquisition sometimes referred to as MR fluoros-
copy [91,93], with vendor specific names BOLUSTRAK
(Philips), CareBolus (Siemens), Fluoro Triggered MRA
(GE). The test bolus method involves the injection of aFigure 28 k-space order for 3D image acquisitions. The concept
of k-space order for 2D image acquisitions was explained previously
(see Part I, Figure 14) [1]. This diagram shows the two approaches to
k-space ordering in 3D imaging that are equivalent to the linear and
centric k-space orders in 2D imaging. In (a), the linear k-space order
for 3D acquisitions begins and ends at the edge of k-space, passing
through the centre of k-space at the mid-point of the acquisition.
For each phase encoding step in one direction, (vertical in this
example) the acquisition steps through all the phase encoding steps
in the other direction (horizontal) so that the lines of k-space are
filled layer by layer. In (b), the centric k-space order for 3D
acquisitions begins at the centre of k-space and works outwards,
adding layers in a pattern of concentric elliptical cylinders of
increasing size. (The number of k-space lines in each phase
encoding direction is usually different, hence the elliptical shape).small volume of contrast agent (typically 2-3 ml), fol-
lowed immediately by a larger volume of saline flush.
Single-slice dynamic scans over the artery of interest are
acquired typically using a spoiled 2D gradient echo pulse
sequence with saturation pulses selectively applied both
above and below the slice to eliminate “inflow” effects. A
single-shot IR gradient echo sequence is also commonly
used, with TI set to null the signal from blood. The delay
time from the start of injection to the start of scan can
then be calculated by using the ‘contrast arrival time’ for
the test bolus, recorded by viewing the dynamic scans.
The aim is to match the centre of the bolus, giving max-
imum concentration, to coincide with the centre of k-
space acquisition. This calculation must therefore also
take account of the bolus injection duration, the acquisi-
tion duration and the k-space order, which is normally
selected as linear for this approach. An advantage of the
test-bolus approach is that it allows the operator to ver-
ify that the injection system is working and the IV access
is patent prior to proceeding to the high resolution ac-
quisition. It also provides the operator with advance
knowledge of the individual patient’s circulation time so
that the main acquisition parameters can be optimised.
These are particularly useful features for operators who
have limited experience with CE-MRA.
The MR fluoroscopy technique may use either a man-
ual or automated trigger to start the CE-MRA acquisi-
tion. The manual trigger method is based upon visual
bolus detection [94]. In this case, a single thick slice is
positioned to include the vessels of interest and images
are acquired and updated continually with a one second
temporal resolution. There are a number of potential
advantages of this approach. First, the operator watches
for the arrival of the contrast agent and triggers the 3D
CE-MRA acquisition manually at the appropriate time.
The operator therefore gains an impression of how fast
the circulation is. This is useful in patients with ex-
tremely slow flow (typically patients with abdominal aor-
tic aneurysms) in whom triggering of the 3D acquisition
as soon as contrast arrives within the upper abdominal
aorta would result in artefacts due to delayed filling of
the iliac arteries. As a single thick slice is used for bolus
detection, the slice encompasses a large amount of the
anatomy. Therefore, sequential enhancement of the right
side of the heart, pulmonary circulation, left heart cham-
bers and aorta is easily visualized. This sequential en-
hancement is useful as the operator has more warning
to co-ordinate the breathing instructions accordingly.
The scanner briefly falls silent after aborting the 2D
fluoroscopic scan. Communication with the patient for
the instruction to breath-hold is therefore unhindered.
Real-time subtraction of the 2D fluoroscopic images
eliminates the background tissue signal and improves
visualization of contrast arrival.
Figure 29 The two principle methods used for timing of the start of the CE-MRA data acquisition. For the test bolus method (top) a small
bolus (1-2 ml) of contrast agent is first injected and a single-slice acquisition is used to acquire a dynamic series of images at approximately 1
second intervals in the region of interest (ROI). The image time series is analysed to determine the time at which the contrast bolus arrived in
the ROI, TROI. The time delay TD for the CE-MRA acquisition is then manually calculated taking into account the time duration of the bolus, TB, the
acquisition time of the MRA pulse sequence, TA and the k-space order (in this case linear). For the fluoroscopic triggering method (bottom) the
first acquisition acquires a dynamic series of images at approximately 1 sec intervals which are reconstructed in real time to allow detection of
contrast arrival. On detection of bolus arrival, a trigger signal is generated either manually or automatically that causes the acquisition to switch
to the CE-MRA pulse sequence. Manual triggering requires the operator to view the dynamic series of images in real time and to initiate the
trigger once they judge that the contrast bolus has adequately progressed into the region of interest. Automated triggering monitors the signal
intensity within a region of interest predefined by the operator on the dynamic image data set. The trigger signal is generated once the signal
intensity rises above a threshold value.
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system continuously monitors the signal intensity within
a single large voxel placed over an artery (e.g. upper ab-
dominal aorta) within the region-of-interest (ROI). The
scan is triggered when the signal intensity rises above a
predetermined threshold value, indicating the arrival of
contrast medium in the selected artery. This approach
removes user dependence from the process but there is
no possibility for the operator to interactively select a
slightly longer scan delay time, for example in a patient
with extremely slow flow in whom there may be a pro-
longed delay between arrival of contrast within the
upper abdominal aorta and the iliac arteries.
Time-resolved contrast-enhanced MRA techniques
The CE-MRA techniques described so far result in a sin-
gle 3D image data set at one time point during the passage
of contrast through the region of interest. Limited dy-
namic information can be obtained by simply repeating
the same acquisition but the maximum ‘frame rate’ for
such an approach is limited by the relatively longacquisition time (typically 10–15 seconds). Time resolved
CE-MRA techniques were developed to overcome this
limitation, reducing the time interval between successive
3D MRA data sets (the temporal resolution) to just a few
seconds whilst maintaining high spatial resolution. The
technique was first published as time resolved imaging of
contrast kinetics (TRICKS) and introduced the idea of div-
iding the 3D k-space into several zones [96]. The image
data within each k-space zone is acquired at different
selected time periods, however the zone at the central part
of k-space is re-acquired more frequently than the other
zones, updating the contrast information more rapidly
than the other higher spatial frequency information
(Figure 30). Each time the contrast information is
updated, the whole k-space data is used to reconstruct a
new image dataset. Vendor specific time-resolved MRA
techniques are now available with GE adopting the
TRICKS method. The keyhole-centric and 4D-Trak (Phi-
lips) and TWIST techniques (Siemens) divide k-space into
just two zones and use differing approaches to fill the
outer part of k-space. Time resolved CE-MRA techniques
Figure 30 This diagram shows the time- resolved MRA approaches offered by three vendors. In each case, the effective frame rate is
defined as the time interval between central zone acquisitions as this determines how often the image contrast is updated. In (a) the vendor
implementation of time resolved imaging with contrast kinetics (TRICKS), divides 3D k-space into four elliptical concentric zones. Data is acquired
initially for all four zones and subsequently the acquisition of the central zone is interleaved with each of the three outer zones in sequence. The
solutions from two other vendors divide k-space into just two zones. In (b) the TWIST technique initially samples the whole of k-space and
subsequently acquires the central zone interleaved with the outer zone. As the outer zone is much larger, although k-space lines are updated
over the full extent of the outer zone, many lines are skipped. The missing lines are then updated in subsequent outer-zone acquisitions. In (c)
the 4D-TRAK technique acquires the whole of k-space at the beginning, followed by between 4–6 consecutive acquisitions of the central zone,
after which the outer zone of k-space is sampled once more. The initial whole k-space acquisition is used as a mask which is subtracted from
later reconstructions to remove the background tissue signal. Subsequent outer zone acquisitions are combined with the preceding 6 central
zone acquisitions (indicated by the curved arrows) to reconstruct time resolved image data sets.
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cular anomalies and arterio-venous malformations.Non-Contrast Enhanced MRA techniques
Non-contrast-enhanced MRA (NCE-MRA) techniques
rely on changes in the MR signal that are caused by the
motion of blood through or within the image plane. There
are three principal flow effects that can occur, depending
on the pulse sequence that is being used: The spin wash-
out effect described in Part 1 of this review [1] gives a
‘dark’ or ‘black’ blood appearance and is characteristic of
spin echo pulse sequences. This effect has sometimes been
used as the basis for ‘black blood‘ angiography. The sec-
ond effect, flow-related enhancement, gives rise to the
bright blood contrast observed with spoiled gradient echo
pulse sequences and is also described in Part 1 [1]. This is
the principal effect that is used as the basis for time-of-
flight (TOF) MRA [97] which for body applications has
been largely replaced by CE-MRA, but still has some ap-
plication in the head for imaging of the circle of Willis
and the sagittal sinus [97,98].The third effect, phase-related signal loss gives rise to
the appearance of signal voids in cine gradient echo
pulse sequences in the presence of flow jets and turbu-
lence. This is due to the intrinsic flow sensitivity of pulse
sequences and is described in more detail in the flow
velocity mapping section (see later). The same principle
that causes this signal loss is used as the basis for phase
contrast angiography or PCA [99,100]. In this case, the
gradient pulses are designed to produce phase changes
which are typically less than 180° for a given velocity
range. In this way, the signal is not completely de-
phased, and the phase information is preserved during
the image reconstruction. Since the phase of the signal
can depend on many factors, it is necessary to perform
at least two acquisitions so that the phase changes due
to the other factors can be removed by subtracting one
image acquisition from the other. In practice, an image
data set is first acquired using a pulse sequence that is
relatively insensitive to flow (or flow compensated), fol-
lowed by one that is sensitive to flow over a particular
range of velocities in one chosen direction. To image
blood flow in all three directions the flow sensitive
Biglands et al. Journal of Cardiovascular Magnetic Resonance 2012, 14:66 Page 32 of 40
http://www.jcmr-online.com/content/14/1/66acquisition is repeated in each of the other two direc-
tions. The signal data from the flow compensated acqui-
sition is then subtracted from each of the flow sensitive
acquisitions, giving a phase contrast image for each flow
direction. Since the phase is unchanged for static pro-
tons, the subtraction completely suppresses the signal
from the background tissue. The final step in the image
reconstruction is to combine the phase contrast data
sets for each direction to calculate a ‘speed’ image. The
signal intensity on PCA images is related to velocity.
The operator prior to the scan sets the flow sensitivity of
the pulse sequence by defining the maximum velocity
range (VENC; +/− max velocity).
More recently, the same principle used for PCA has
been modified to provide a NCE-MRA technique to image
the peripheral arteries, exploiting the difference in flow
velocities between systole and diastole. Whereas PC-MRA
is normally used in combination with a 2D or 3D gradient
echo pulse sequence, this method uses two 3D fast (or
turbo) spin echo acquisitions, synchronised first to systole
and then diastole [98,99,101]. Phase-related signal loss re-
lating to higher velocities in systole is not present in dia-
stole and the difference in signal is used to generate an
arteriogram by subtraction of the two data sets. Techni-
ques that apply this principle are now available commer-
cially, implemented as Flow-Spoiled Fresh Blood Imaging
(FBI) by Toshiba, Native SPACE MRA by Siemens,
TRANCE by Philips and InHance 2D Inflow by GE.
A further recent development is the use of both 2D and
3D bSSFP pulse sequences to perform NCE-MRA [19,99].
The combination of their intrinsically high signal from
blood and the use of fat suppression techniques provides a
simple, flow-independent method of imaging vessels.
Vendor implementations of this approach include FIESTA
with Fat Sat, Balanced FFE with SPIR, True FISP with Fat
Sat. The main disadvantage of this approach is that both
the arterial and venous system is imaged, as well as other
fluid-filled ducts, although the venous suppression techni-
ques used in TOF-MRA can also be applied here to re-
move unwanted venous signal. Balanced SSFP techniques
have also been combined with a technique known as ar-
terial spin labelling (ASL) to provide high quality arterio-
grams of both the renal and carotid arteries [19,98,99].
Vendor implementations of this technique include time-
SLIP by Toshiba, Native TrueFISP by Siemens, b-
TRANCE by Philips and InHance Inflow IR by GE.
Coronary MRA with respiratory gating using navigator
echoes
Imaging of the coronary arteries is one of the most chal-
lenging applications of cardiac MR imaging due to their
small size and their motion with the cardiac and respira-
tory cycles. The most common pulse sequence used to
image the coronary vessel lumen is a three dimensional(3D) gradient echo pulse sequence, combined with a series
of preparation pulses to optimise the vessel contrast
[20,102]. The use of a gradient echo pulse sequence for
data acquisition provides a relatively enhanced signal from
flowing blood. The 3D data acquisition allows thin slices
to be acquired to achieve a high resolution data set. The
acquisition of a 3D data set with high resolution in all
three directions requires a long acquisition time, even
when using a fast or turbo gradient echo sequence. This
acquisition method cannot therefore be combined with
breath-holding and the acquisition must instead be both
cardiac triggered and respiratory gated. Respiratory gating
requires the patient’s respiratory cycle to be monitored.
The data acquisition is then controlled or gated
(Figure 31a), such that data is acquired predominantly
from one part of the respiratory cycle. This is usually
chosen as end expiration as it is assumed that the respira-
tory cycle for the majority of patients dwells there for
longer periods. The simplest way to monitor the respira-
tory cycle is to use a pneumatic bellows system held
against the abdomen with an adjustable belt. For the high
spatial resolution required to image the coronary arteries,
however, a more accurate method is employed for real-
time monitoring of the diaphragm position using naviga-
tor echoes (Figure 31b). Navigator echoes are generated
using a specially designed rf pulse (or pulses) to excite a
column of tissue through the diaphragm immediately be-
fore each image data acquisition. A line of signal is recon-
structed from each navigator echo and displayed as a
trace. The boundary between the low signal intensity in
the lung and the relatively high signal intensity in the liver
creates an edge that can easily be detected and used as a
gating signal which accurately reflects the diaphragm pos-
ition and is used to determine whether the data is
accepted or rejected. The accuracy of this method allows
narrow gating windows to be set (typically 5 mm) for high
resolution applications such as coronary artery imaging.
Typically the position of the gating window is set auto-
matically based upon an in-line analysis of the respiratory
navigator prior to the start of each image data acquisition.
The magnetisation preparation scheme for coronary im-
aging includes the rf navigator pulse and a frequency se-
lective fat suppression pulse that is used to suppress the
fat signal surrounding the coronary arteries (Figure 32a).
The image data acquisition is also preceded by a T2-
preparation scheme [102]. This scheme uses the same
series of pulses as a fast spin echo train (90°-180°-180°-
180°-180°) which produces a transverse magnetisation that
is T2-weighted. The final pulse in this T2-preparation
scheme is a 90° that restores this magnetisation along the
z-axis. This component of the preparation scheme helps
to suppress the signal from the myocardium (short T2)
relative to the blood signal (long T2). The 3D fast or turbo
gradient echo pulse sequence is chosen for data
Figure 31 Respiratory gating and navigator echoes. This figure illustrates the principle behind the use of navigator echoes to gate the image
data acquisition according to a particular time period within the respiratory cycle. The diagram in (a) shows a cardiac triggered data acquisition
with a trigger delay chosen at mid-diastole to minimise the effect of cardiac motion. A curve representing the diaphragm position during
respiratory motion is shown above. The effect of respiratory motion is limited by gating the data acquisition, so that image data is only accepted
when the diaphragm position lies within a predefined ‘window’ corresponding to end expiration. A navigator pulse (shown in red) is applied
immediately before the image data acquisition to excite a column of tissue cutting through the right hemi-diaphragm at right angles (b). The
resultant navigator echo is frequency encoded along the length of the column and the navigator echo signal is analysed using a Fourier
transform to produce a line of signal. The line signal from each successive R-R interval is added to a navigator display. A computer algorithm
detects where the signal intensity changes from a high value (liver) to a low value (lung), representative of the diaphragm position. Where the
diaphragm position falls within a predefined gating window the image data acquisition is accepted (indicated by the green dashes). Where the
diaphragm position falls outside the gating window the data acquired is rejected and the acquisition is repeated until the diaphragm position
again falls within the gating window.
Figure 32 Respiratory navigator-gated 3D Coronary MRA pulse sequence. The key features of a navigator-gated 3D coronary MRA pulse
sequence are shown in (a). The image data acquisition is typically performed using a 3D fast or turbo gradient echo (FGE) pulse sequence with a
trigger delay set to acquire during mid-diastole. The image data acquisition is typically preceded by three preparation pulses, a T2-preparation
pulse, the navigator pulse (see Figure 31) and a frequency-selective fat suppression pulse (see Figure 2 and Figure 5). The fat suppression pulse is
necessary to suppress the signal from fat surrounding the coronary arteries and is applied immediately before the image data acquisition to
maximise the effectiveness of fat suppression. The T2 preparation pulse is used to reduce the signal from the myocardial muscle (short T2)
relative to that of the blood (long T2). This prep pulse consists of a 90° rf pulse followed by a series of 180° rf pulses, similar to a multi-echo spin
echo pulse sequence. This produces magnetisation in the transverse plane that is T2-weighted. The T2-weighted transverse magnetisation is then
rotated back to the z-axis by a second 90° rf pulse, resulting in z-magnetisation for myocardium that is reduced relative to that of the blood
within the coronary arteries. This improves the contrast of the resultant MRA images. Four slices from a 3D coronary MRA dataset are shown in
(b). Note the absence of fat signal from around the coronary arteries and the reduced signal contribution from the myocardium.
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acquired, allowing curved multi-planar reconstruction of
images along the path of each coronary artery
(Figure 32b). Coronary MRA may be performed either
using two targeted thin volumes to separately cover the
left and right coronary artery systems [20], or to acquire a
much larger single 3D volume acquisition of the whole
heart, from which reconstructed views of each artery are
obtained [103].
Flow velocity mapping
Intrinsic flow sensitivity of pulse sequences
Qualitative assessment of blood flow patterns can be
performed using cine gradient echo pulse sequences.
Spoiled gradient echo pulse sequences (in comparison to
bSSPF sequences) are particularly useful for the visual-
isation of flow jets associated with regurgitant andFigure 33 This diagram illustrates how velocity-related phase shifts a
opposite magnetic field gradients applied in succession, (bipolar grad
amplitudes G and duration t, separated by a time T. Immediately after the
phase (top left). When the first positive gradient pulse is applied (1), spins a
position along the gradient. When the second negative gradient pulse is a
equal decrease in magnetic field, causing the spins to move back into pha
will have moved to position B, and experience an additional decrease in m
position A. The signal from moving blood therefore acquires a phase shift,
as shown (top right). Bipolar gradient pulses are used to design velocity-se
be seen that the velocity-related phase shift, φ, is also proportional to amp
Velocity sensitive pulse sequences are designed to be sensitive over differe
parameters.stenotic valves, stenotic vessels and septal defects, due
to their inherent sensitivity to the presence of these flow
jets [104,105]. This sensitivity arises due to the motion
of spins within the flowing blood along the magnetic
field gradients that are applied as part of the gradient
echo pulse sequence [23,106]. The formation of the gra-
dient echo requires any de-phasing of the magnetisation
caused by either the slice selection or frequency encod-
ing gradients to be reversed at the echo time (TE). This
is achieved by applying two gradients along the same
direction but with opposite signs [1]. This combination
is known as a bipolar gradient pulse pair. The second
gradient reverses (re-phases) the de-phasing caused by
the first gradient for stationary tissue, but for spins
within flowing blood that change their position along
the gradient during the interval between the two gradi-
ents (Figure 33), the complete reversal by the secondre caused by blood flowing along the direction of two equal but
ient pulses). Two gradient pulses are shown with gradient
rf pulse is applied, both moving and stationary spins have the same
t position A experience an increase in magnetic field due to their
pplied [2], stationary spins that remain at position A experience an
se with one another. Spins in moving blood with velocity v, however,
agnetic field that is proportional to the distance moved, vT, from
φ, relative to that of stationary tissue, that is proportional to velocity, v
nsitive pulse sequences. From the equation shown (top centre) it can
litude G, the duration, t, and the separation, T, of the gradient pulses.
nt velocity ranges through careful choice of these gradient pulse
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ent is not achieved. As a result, the phase of the trans-
verse magnetisation within flowing blood after the two
gradient pulses is different from the phase of transverse
magnetisation within stationary tissue and the difference
is proportional to the velocity of the blood in the direc-
tion of the applied gradient [22]. For a certain velocity,
the size of this phase difference depends on the flow
sensitivity of the pulse sequence. This depends on the
amplitude (or slope) of the bipolar gradients G, their
duration, t and the time interval between the two gradi-
ent pulses, T (Figure 33).
Appearance of flow voids
Gradient Echo-based pulse sequences normally produce
images with a ‘bright-blood’ appearance. In the presence
of flow jets however, a signal void is often seen at the lo-
cation of the jet (Figure 34). This effect is commonly
observed when imaging regurgitant valves, stenotic ves-
sels or flow through septal defects [105]. The signal void
is caused by a de-phasing of the magnetisation in
the presence of the jet. This is a consequence of the
velocity-related phase shift caused by motion along the
magnetic field gradients as described in the previous sec-
tion. The flow jet contains a large range of velocities
(sometimes referred to as a velocity gradient). This
causes a large range of phase shifts, causing de-phasing
of the transverse magnetisation and therefore resulting
in signal loss (Figure 34). The flow-related signal void isFigure 34 Signal losses caused by velocity gradients. This diagram illus
regurgitant flow jets. The two images (bottom left) show signal loss (white
early diastole. Flow jets consist of a large range of velocities, from very high
edge of the jet (top left). The change in velocity from the centre to the ed
that when bipolar gradients are applied within imaging pulse sequences, v
velocities due to a velocity gradient within a pixel, this results in a large ran
signal loss within that pixel. Outside the jet there is only a small range of voften qualitatively related to the size and severity of the
flow jet and is sometimes used to grade the severity of
regurgitation [107]. Qualitative assessment of this kind
must be done with caution, as the size of the signal void
also depends on the pulse sequence type, the echo time
and a number of other parameters that affect the im-
aging gradients strength and duration. For example, in-
creasing the echo time increases the apparent size of the
flow jet [108]. Additionally, the same flow jet visualised
using a bSSFP pulse sequence is smaller than when
visualised using a spoiled gradient echo pulse sequence
with equivalent imaging parameters. Common solutions
to remove or reduce flow-related signal loss are to re-
duce the echo time, use flow compensation or use a
bSSFP pulse sequence that is less flow sensitive than a
spoiled gradient echo pulse sequence. It has been shown
that for spoiled gradient echo pulse sequences, a TE of
less than 3.6 ms significantly reduces signal loss
[105,109] but may require use of a high receiver band-
width, and / or partial (asymmetric) echo sampling, both
of which reduce SNR. Flow compensation, (also known
as Gradient Moment Nulling or Gradient Motion
Rephasing), can be applied to reduce the flow sensitivity
of a pulse sequence. It is normally achieved by adding
one or more gradient pulses to the pulse sequence where
there is already a bipolar gradient pulse. The purpose of
the additional gradient pulse(s) is to reduce or nullify
the velocity-dependent phase shift caused by motion
along the gradient. This reduces flow de-phasing andtrates how signal losses occur in the presence of stenotic or
arrows) caused by aortic valve regurgitation at two end systole and
velocities at the centre of the jet, to relatively low velocities at the
ge of the jet is often referred to as a velocity gradient. Figure 33 shows
elocity related phase shifts occur. Where there is a large range of
ge of phase shifts (right), causing significant dephasing and therefore
elocities leading to negligible dephasing and no signal loss.
Figure 35 A retrospectively-gated, cine spoiled gradient echo pulse sequence (top) is shown in detail for four cardiac phases. In this
example the standard imaging gradients are modified in the slice-selection direction to encode flow velocity components perpendicular to the
image plane. For each cardiac phase the gradient echo pulse sequence is acquired twice, with two different flow sensitivities, indicated here by
the red and green gradient pulses. The heart phase interval or ‘effective TR’ of the velocity encoded sequence is double the actual TR of the
gradient echo pulse sequence. The Mx and My components of the MR signal are used to calculate both the signal magnitude, M, and the signal
phase, φ, for each pixel. The phase maps for the two different flow sensitivities are subtracted to remove background phase shifts, creating a
velocity map, which contains only velocity-related phase shifts due to the difference in flow velocity sensitivity between the two acquisitions. The
flow sensitivities are chosen such that a subtracted phase difference of 180° corresponds to a predefined maximum velocity or VENC. The sign of
the subtracted phase indicates the direction of flow along the encoded direction. The value of relative phase shift is mapped onto the pixel
intensity scale such that a zero subtracted phase (stationary tissue) maps on to the centre of the pixel intensity scale (mid-grey). Positive and
negative subtracted phases (corresponding to opposite directions of flow) are mapped onto higher and lower pixel intensities, respectively.
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echo time which may negate any benefit in the presence
of signal loss caused by flow jets.
Flow velocity encoding and velocity mapping
This inherent flow sensitivity is exploited to enable the
quantification of blood flow velocity by generating
images, known as phase maps, in which pixel intensity
depends upon the phase of the transverse magnetisation,
rather than its magnitude [23,24]. There are however a
number of potential causes of relative change in phaseof the transverse magnetisation. These include phase
changes due to motion along more than one gradient
direction (arising from velocity components in these
other directions) and phase changes due to magnetic
field inhomogeneities.
The phase changes due to the above causes must be
accounted for in order to isolate the change that is due
to motion along the desired gradient direction. This is
achieved by performing two consecutive acquisitions for
each phase encoding step. The two acquisitions are iden-
tical other than that they have different flow sensitivities
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the velocity encoding direction. The flow sensitivity is
determined by the amplitude, duration and time separ-
ation of the bipolar flow-encoding gradients in that dir-
ection. Once the image data acquisition is complete,
phase maps from the two acquisitions are calculated and
subtracted to produce a velocity map. The subtracted
velocity map contains only phase shifts that are related
to velocity components in the flow-encoding direction.
Phase changes due to other causes, including velocity
components in other directions and magnetic field inho-
mogeneities are removed by the subtraction.
Velocity maps are generally displayed using a grey scale
with stationary tissue being displayed as mid-grey, with
velocities in forward (positive) and reverse (negative)
directions being represented as higher (towards white)
and lower (towards black) pixel intensities (Figure 35).
The maximum measurable velocity range, often re-
ferred to as the VENC, is defined by the MR operator. It
is determined by the difference in the flow sensitivities of
the two acquisitions. Selecting a VENC that is too low is
a common pitfall of velocity-encoded cine MR imaging
[23,24]. The imaging of blood flow with velocities that
are higher than the chosen VENC results in aliasing of
the measured velocity value, with positive velocities beingFigure 36 This figure illustrates some of the common pitfalls encoun
transaxial magnitude image and velocity map with ‘through-plane’ velocity
In (b), the maximum velocity is within the VENC chosen for the velocity-en
ascending aorta are less than 180° and are shown as high pixel intensities.
the ascending aorta (arrow) appear as negative velocities. This artefact, kno
are interpreted as negative phase shifts and are mapped on to the lower p
and velocity map acquired in an oblique sagittal plane to demonstrate flow
plane’ to demonstrate velocity components in the head-feet direction. In (f
is lower than the VENC so that no aliasing is visible. For image (g) the VEN
velocity encoding direction has been incorrectly chosen to encode velocity
transverse components of blood flow velocity are visible in the aorta.displayed as negative velocities and vice versa (Figure 36).
The presence of flow jets or turbulence presents a further
pitfall when attempting to quantify blood flow velocities
as they can cause signal loss. At low signal magnitudes,
calculation of the signal phase becomes unreliable,
resulting in spurious velocity measurements [105,109].
This pitfall can be avoided by selecting a short echo time
(below 3.6 ms) for the cine velocity mapping gradient
echo pulse sequence. Another common pitfall arises
when the wrong flow encoding direction is selected by
the operator (Figure 36). More detailed considerations
relating to acquisition and analysis of velocity-encoded
cine MR image data is beyond the scope of this review
but are covered elsewhere [23,24,105].
Conclusion
This review has outlined the key physical principles that
underlie the more advanced cardiac MR imaging techni-
ques most commonly used in clinical practice. The basic
principles of oedema imaging, myocardial cine tagging,
myocardial perfusion, late enhancement imaging, mag-
netic resonance angiography and velocity mapping have
been explained. Key imaging parameters have been
defined, explaining their influence on image contrast,
resolution and acquisition time. Where appropriate,tered with velocity-encoded MR imaging. Images (a) and (b) show a
encoding demonstrating forward flow in the ascending aorta (arrows).
coded acquisition, so that the phase shifts for all the pixels within the
In image (c), the VENC is set too low and the pixels at the centre of
wn as ‘velocity aliasing’ arises because phase shifts greater than 180°
ixel intensity scale (d). Images (e) and (f) show a magnitude image
in the aortic arch. The velocity encoding direction is chosen as ‘in-
), the maximum velocity in both the ascending and descending aorta
C has been set too low resulting in velocity aliasing. For image (h) the
components through the image plane, so that only relatively low
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remedies of common image artefacts have been
explained. Further detailed reading is provided through
the provision of key references. This review should be a
useful resource from clinicians who wish to gain a
greater understanding of the underlying physics of CMR.
Additional files
Additional file 1: Perfusion defect movie. Dynamic Contrast
Enhanced (DCE-MRI) stress perfusion image movie. Contrast agent causes
signal enhancement in the right ventricle followed by the left ventricle
followed by the healthy myocardium. Coronary artery disease reduces or
obstructs flow to the septal and anterior myocardium resulting in an area
of hypo-enhancment (relative to the enhanced myocardium), known as a
perfusion defect.
Additional file 2: Maximum intensity projection (MIP). A PowerPoint
animation showing how a projection angiogram is formed using a
maximum intensity projection (MIP). In this simplified example a lateral
projection of a simulated bifurcating vessel is generated from a series of
transaxial slices. Each mouse click projects the maximum pixel data
encountered within a single slice on to a single row of pixels. This
process continues until all the slices in the MRA volume have been
projected onto the final MIP image.
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